Medicines Shortages Update
Last Updated 30 October 2026
- Medicines Shortages List Nov 2026
- Medicines Shortages List Oct 2026
- Medicines Shortages List Sep 2026
- Medicines Shortages List Aug 2026
- Medicines Shortages List July 2026
- Medicines Shortages List June 2026
- Medicines Shortages List May 2026
- Medicines Shortages List Apr 2026
- Medicines Shortages List Mar 2026
- Medicines Shortages List Feb 2026
- Medicines Shortages List Jan 2026
- Medicines Shortages List Dec 2025
NOTE: For any reimbursement queries relating to EMPs please contact PCRS – ExemptMed@hse.ie.
| Tradename | Pack Size | GMS No | Expected Resupply Date | Manufacturer | Date Notified | Date Last Updated | Date Resolved | Reason | Generic Name | Note | Reimbursement of EMP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACETYLCYSTEINE ESSENTIAL 600MG EFF TABS | 30TABS | 64004 | 30th April 2027 | ASCOT LABS | 18-Jun-24 | 29-Oct-26 | No reason provided | ACETYLCYSTEINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| ACIDEX LIQUID ORAL SUSPENSION | 200ML | Unable to provide date | PINEWOOD | 23-Jan-25 | 09-Oct-26 | Reformulation / regulatory issue | SOD ALG/SOD H CARB/CACARB | As per Pinewood. | |||
| ACIDEX LIQUID ORAL SUSPENSION | 500ML | Unable to provide date | PINEWOOD | 23-Jan-25 | 09-Oct-26 | Reformulation / regulatory issue | SOD ALG/SOD H CARB/CACARB | As per Pinewood. | |||
| ADDIPHOS CONC FOR SOLN/INF 20ML POA | 10VIAL | No return date for the Irish licensed stock. BSR available | FRES KABI | 16-Oct-26 | API shortage / unavailability | POTASSIUM/PHOSPHAT/SODIUM | As per HPRA / FK | ||||
| ADENOCOR 3MG/ML SOLN FOR INJ 2ML | 6VIAL | 31st January 2027 | SANOFI AVE | 12-May-26 | 27-Oct-26 | No reason provided | ADENOSINE | As per Sanofi. HPRA shows 30.06.27 return date. EMP stock available via PharmaSource. | |||
| ADENOSINE 3MG/ML SOLN/INJ PFS 4ML POA | 10PACK | Mid November 2026 | FRES KABI | 29-May-26 | 19-Oct-26 | Unexpected increased demand | ADENOSINE | As per Fresenius | |||
| ADRENALINE EPIN 1MG/10ML SOLN/INJ PFS | 10SYR | In Stock | LAB AGUETT | 28-Sep-26 | 06-Oct-26 | 06-Oct-26 | Shipping delay / distribution issue | EPINEPHRINE | No longer on HPRA list | ||
| ADRENALINE EPINEPHRINE 1:1000 INJ 1ML | 10AMP | BSR available. No confirmed timeline at the moment on the IE packs. | ADVANZ | 05-Jun-26 | 01-Sep-26 | Unexpected increased demand | EPINEPHRINE | As per Advanz. No shortage listed on HPRA list 01.09.26 | |||
| AIMOVIG 140MG SOLN FOR INJ PFP | 1PENS | 89091 | Back In Stock | NOVARTIS | 11-Sep-26 | 27-Oct-26 | 23-Oct-26 | Unexpected increased demand | ERENUMAB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| AIMOVIG 70MG SOLN FOR INJ PFP | 1PENS | 89090 | 6th November 2026 | NOVARTIS | 11-Sep-26 | 27-Oct-26 | Increased sales & capacity at plant | ERENUMAB | As per HPRA / Novartis | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ALDACTONE 100MG FC TABS | 28TABS | 79782 | 14th December 2026 | PFIZER | 03-Aug-26 | 27-Oct-26 | Unexpected increased demand | SPIRONOLACTONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ALDACTONE 100MG TABS | 100TABS | 79596 | 9th November 2026 | PFIZER | 08-Sep-26 | 16-Oct-26 | Unexpected increased demand | SPIRONOLACTONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ALDACTONE 50MG FC TABS | 100TABS | 10510 | In Stock | PFIZER | 19-Oct-26 | 27-Oct-26 | 27-Oct-26 | Manufacturing delay | SPIRONOLACTONE | No longer on HPRA list | |
| ALENDRONATE/COLECA TEVA 70MG/2800IU TABS | 4TABS | 13480 | 23rd November 2026 | TEVA | 27-Apr-26 | 27-Oct-26 | Manufacturing delay | ALENDRONIC AC/COLECALCIFE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ALENDRONATE/COLECA TEVA 70MG/5600IU TABS | 4TABS | 13481 | OOS expected 9th November. Return date 16th December 2026 | TEVA | 26-Oct-26 | Manufacturing delay | ALENDRONIC AC/COLECALCIFE | As per HPRA | |||
| ALPRAZOLAM 0.5MG TABS | 100TABS | 15917 | TBC | ROWA | 08-Jun-26 | 21-Sep-26 | Increase in sales | ALPRAZOLAM | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMIDEX 1MG FC TABS ANASTROZOLE | 28TABS | 11201 | 30th November 2026 | CLONMEL | 27-Oct-26 | Manufacturing delay | ANASTROZOLE | As per HPRA | |||
| AMLODIPINE TEVA 10MG TABS | 28TABS | 15079 | Nov-26 | TEVA | 11-Sep-26 | 08-Oct-26 | Manufacturing delay | AMLODIPINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMLODIPINE/VALSARTAN MYLAN 10/160MG TAB | 28TABS | 24533 | Back In Stock | VIATRIS | 26-Nov-25 | 07-Oct-26 | 07-Oct-26 | Manufacturing delay | AMLODIPINE/VALSARTAN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| AMLODIPINE/VALSARTAN MYLAN 5MG/160MG TAB | 28TABS | 24532 | 16th December 2026 | VIATRIS | 28-Apr-26 | 07-Oct-26 | Manufacturing delay | AMLODIPINE/VALSARTAN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMOROLFINE 5%W/V MEDICATED NAIL LACQUER | 5ML | 31464 | Jan-27 | ROWA | 06-Feb-26 | 27-Jul-26 | Manufacturing delay | AMOROLFINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ANAPEN 500MCG/0.3ML SOLN/INJ ADULT PFS | 2SYR | 39108 | 30th November 2026 | LINCOLNMED | 04-Sep-24 | 12-Oct-26 | Manufacturing issues | EPINEPHRINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ANASTROZOLE TEVA 1MG FC TABS | 28TABS | 12930 | Nov-26 | TEVA | 08-Sep-26 | 29-Oct-26 | Manufacturing delay | ANASTROZOLE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ANIDULAFUNGIN 100MG PDR FOR CONCSOLN/INF | 1VIAL | 30th October 2026 | ROWA | 18-Sep-26 | 27-Oct-26 | Production issues | ANIDULAFUNGIN | As per HPRA | |||
| ANTI-HIST ALLERGY 1MG/ML ORAL SOLUTION | 200ML | Back In Stock | CLONMEL | 10-Apr-26 | 12-Oct-26 | 12-Oct-26 | Manufacturing delay | CETIRIZINE | As per Clonmel | ||
| APREPITANT ACCORD 125MG HARD CAPS | 5CAPS | 28903 | Jun-27 | ACCORD HC | 04-Feb-26 | 15-Sep-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis | |
| APREPITANT ACCORD 125MG/80MG CAPS 3 DAY | 1PACK | 28906 | Jun-27 | ACCORD HC | 18-Feb-25 | 15-Sep-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis | |
| APREPITANT ACCORD 80MG HARD CAPS 2 DAY | 1PACK | 28904 | Jun-27 | ACCORD HC | 12-May-25 | 15-Sep-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis | |
| ARAVA 20MG FC TABS | 30TABS | 12352 | In Stock | SANOFI AVE | 05-Oct-26 | 15-Oct-26 | 08-Oct-26 | Manufacturing delay | LEFLUNOMIDE | No longer on HPRA list | |
| ARCOXIA 30MG FC TABS | 28TABS | 14001 | OOS 29th October. Return date 14th December 2026 | ORGANON | 15-Oct-26 | 19-Oct-26 | Manufacturing delay | ETORICOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ARIPIL 10MG FC TABS DONEPEZIL | 28TABS | 12283 | Pending | VIATRIS | 08-Sep-26 | 28-Sep-26 | Unexpected increased demand | DONEPEZIL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ARIPIL 5MG FC TABS DONEPEZIL | 28TABS | 12275 | 1st January 2027 | VIATRIS | 18-Feb-26 | 25-May-26 | Unexpected increased demand | DONEPEZIL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ARIPIPRAZOLE TEVA 5MG TABS | 28TABS | 36913 | Dec-26 | TEVA | 28-Aug-26 | 07-Sep-26 | Manufacturing delay | ARIPIPRAZOLE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ASACOLON 800MG GAST RES TABS | 90TABS | 14325 | 30th October 2026 | TILLOTTS | 21-Oct-26 | Quality issue | MESALAZINE | As per HPRA | |||
| ATGAM 50MG/ML CONC/SOLN/INF 5ML POA | 5AMP | 18th November 2026 | PFIZER | 07-Aug-26 | 29-Oct-26 | Unexpected increased demand | ANTITHYMO IMMUNOGLOB EQUI | As per HPRA | |||
| ATOMOXETINE ACCORD 100MG HARD CAPS | 28CAPS | 36009 | Jun-27 | ACCORD HC | 06-Jun-24 | 15-Sep-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 10MG HARD CAPS | 28CAPS | 36001 | Jun-27 | ACCORD HC | 06-Jun-24 | 15-Sep-26 | Manufacturing delay | ATOMOXETINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 10MG HARD CAPS | 7CAPS | 36000 | Jun-27 | ACCORD HC | 06-Jun-24 | 15-Sep-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 18MG HARD CAPS | 28CAPS | 36002 | Jun-27 | ACCORD HC | 28-Jul-26 | 15-Sep-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 25MG HARD CAPS | 28CAPS | 36005 | Jun-27 | ACCORD HC | 06-Jun-24 | 15-Sep-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 25MG HARD CAPS | 7CAPS | 36004 | Jun-27 | ACCORD HC | 06-Jun-24 | 15-Sep-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 40MG HARD CAPS | 28CAPS | 36006 | Jun-27 | ACCORD HC | 28-Jul-26 | 15-Sep-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 60MG HARD CAPS | 28CAPS | 36007 | Pending | ACCORD HC | 16-Sep-26 | 30-Sep-26 | Manufacturing delay | ATOMOXETINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 80MG HARD CAPS | 28CAPS | 36008 | Jun-27 | ACCORD HC | 28-Jul-26 | 15-Sep-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATORVASTATIN 20MG FC TABS | 28TABS | 41938 | Oct-26 | ACCORD HC | 13-Jul-26 | 07-Aug-26 | Manufacturing delay | ATORVASTATIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 20MG FC TABS | 28TABS | 41966 | Mar-27 | VIATRIS | 07-Apr-25 | 04-Sep-26 | Manufacturing delay | ATORVASTATIN | As per Viatris. HPRA shows return date as Pending | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 40MG FC TABS | 28TABS | 41967 | Mar-27 | VIATRIS | 21-Mar-25 | 04-Sep-26 | Manufacturing delay | ATORVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 80MG FC TABS | 28TABS | 41968 | Mar-27 | VIATRIS | 14-Apr-25 | 04-Sep-26 | Manufacturing delay | ATORVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATOZET 10MG/10MG FC TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATOZET 10MG/40MG FC TABS | 30TABS | 36862 | 2nd November 2026 | ORGANON | 10-Sep-26 | 23-Sep-26 | Manufacturing delay | EZETIMIBE/ATORVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATOZET 10MG/40MG TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATOZET 10MG/80MG TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATRACURIUM BESILATE 10MG/ML 2.5ML | 5VIAL | Awaiting update | CARAGEN | 17-Jan-25 | 27-Jul-26 | Awaiting information | ATRACURIUM | As per Caragen | |||
| AZACITIDINE ACCORDÂ 25MG/ML PDR/SUSP/INJ | 1VIAL | No return date (150ML) | ACCORD HC | 26-Mar-26 | 21-Apr-26 | Reason provided | AZACITIDINE | As per Accord | |||
| AZROMAX 250MG FC TABS AZITHROMYCIN | 6TABS | 13822 | 2nd November 2026 | VIATRIS | 31-Jul-26 | 11-Aug-26 | Unexpected increased demand | AZITHROMYCIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BACTROBAN 2% NASAL OINTMENT | 3G | 13773 | 16th November 2026 | GSK MED | 19-Oct-26 | 28-Oct-26 | Quality issue | MUPIROCIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BENDAMUSTINE 100MG PDR/CONC/SOLN FOR INF | 1VIAL | TBC | TEVA | 22-Oct-26 | 27-Oct-26 | Manufacturing delay | BENDAMUSTINE | As per Teva | |||
| BENDAMUSTINE 100MG PDR/CONC/SOLN FOR INF | 5VIAL | No return date | ACCORD HC | 23-Jan-25 | 27-Mar-26 | No reason pprovided | As per Accord | ||||
| BENDAMUSTINE 25MG PDR/CONC/SOLN FOR INF | 1VIAL | TBC | TEVA | 03-Sep-26 | No reason provided | BENDAMUSTINE | As per Teva | ||||
| BENDROFLUMETHIAZIDE 2.5MG TABS | 28TABS | 36979 | Q4 2026 | AZURE | 28-Jan-25 | 05-Oct-26 | Undergoing testing | BENDROFLUMETHIAZIDE | As per Azure (HPRA shows pending return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BENDROFLUMETHIAZIDE 5MG TABS | 28TABS | 36980 | Q4 2026 | AZURE | 16-Jul-25 | 05-Oct-26 | Delay in securing EU QP release services | BENDROFLUMETHIAZIDE | As per Azure (HPRA shows pending return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BENZYL BENZOATE 25% APPLICATION CUT EMUL | 150ML | Pending | GRDNR FAM | 31-Jul-25 | 09-Sep-26 | API shortage / unavailability | BENZYL BENZOATE | As per HPRA 07.09.26 | |||
| BENZYL BENZOATE 25% APPLICATION CUT EMUL | 1L | Pending | GRDNR FAM | 08-Sep-26 | API shortage / unavailability | BENZYL BENZOATE | As per HPRA | ||||
| BEPANTISEPTIC FIRST AID CREAM | 55G | Back In Stock | BAYER | 19-Aug-26 | 12-Oct-26 | 09-Oct-26 | No reason provided. | PHENOL/CHLORHEXIDINE | As per Bayer CH | ||
| BETNESOL 0.1% EYE EAR & NOSE DROPS | 10ML | 15113 | 1st February 2027 | RPH | 29-Apr-26 | 30-Oct-26 | Manufacturing delay | BETAMETHASONE SODIUM PHOS | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BETNESOL N EYE EAR & NASAL DROPS | 10ML | 15121 | 1st February 2027 | RPH | 01-May-26 | 28-Oct-26 | Manufacturing delay | BETAMETHASON NA PHOS/NEOM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BRALTUS 10MCG CAPS & ZONDA INHALER | 30CAPS | 61508 | 19th October 2026 | TEVA | 25-Sep-26 | 15-Oct-26 | Manufacturing delay | TIOTROPIUM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BRILLPHALAC 3.335G/5 ML ORAL SOLUTION | 300ML | Q4 2026 | WINDZOR PH | 17-Feb-25 | 07-Jul-26 | Change of manufacturing site | LACTULOSE | As per Windzor. HPRA shows pending return date | |||
| BRILLPHALAC 3.335G/5 ML ORAL SOLUTION | 500ML | 67152 | Q4 2026 | WINDZOR PH | 17-Feb-25 | 07-Jul-26 | Change of manufacturing site | LACTULOSE | As per Windzor. HPRA shows pending return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BRINAVESS 20MG/ML CONC FOR SOLN/INF 25ML | 1VIAL | No confirmed timeline (UK packs may be avail) | ADVANZ | 17-Nov-25 | 25-Aug-26 | Regulatory issue | VERNAKALANT | As per Advanz (ULM UK packs may be avail). HPRA shows 30.03.27 return date | |||
| BROLENE 0.1% EYE DROPS SOLN | 10ML | Mid December 2026 | CLONMEL | 21-May-26 | 16-Sep-26 | Manufacturing delay | PROPAMIDINE | As per Clonmel | |||
| BUDESONIDE TEVA PHARMA 1MG/2ML NEB SUSP | 20NEB | 13341 | 11th November 2026 | TEVA | 02-Jan-25 | 27-Oct-26 | Manufacturing delay | BUDESONIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CALCICHEW D3 FORTE 500MG/400IU CHEW TABS | 60TABS | 15890 | In Stock | ATHENA | 17-Sep-26 | 07-Oct-26 | 06-Oct-26 | Manufacturing delay | CA CARBONATE/COLECALCIFER | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CALCICHEW D3 FORTE DBLE STR 1000MG/800IU | 30TABS | 13342 | In Stock | ATHENA | 17-Sep-26 | 12-Oct-26 | 12-Oct-26 | Unexpected increased demand | CA CARBONATE/COLECALCIFER | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CALCIPOTRIOL/BETAMETH 50MCG+0.5MG/G OINT | 30G | 31599 | 5th January 2027 (ETA) | ROWA | 30-Jul-26 | 05-Oct-26 | Increase in sales | CALCIPOTRIOL/BETAMETHASON | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CALVEPEN 333MG TABS | 100TABS | 16330 | Mid January 2027 | CLONMEL | 18-Sep-26 | 12-Oct-26 | Manufacturing delay | PHENOXYMETHYLPENICILLIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CALVEPEN 666MG TABS | 100TABS | 16397 | End November 2026 | CLONMEL | 21-Sep-26 | 12-Oct-26 | Manufacturing delay | PHENOXYMETHYLPENICILLIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CANDESARTAN 16MG TABS | 28TABS | 15419 | In Stock | ACCORD HC | 17-Sep-26 | 14-Oct-26 | 14-Oct-26 | Unexpected increased demand | CANDESARTAN | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CAPECITABINE ACCORD 500MG FC TABS | 120TABS | 88139 | In Stock | ACCORD HC | 10-Sep-26 | 29-Oct-26 | 28-Oct-26 | Manufacturing delay | CAPECITABINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CARBIMAZOLE 20MG TABS | 56TABS | 67151 | Mid November 2026 | AZURE | 27-Oct-26 | No reason provided | CARBIMAZOLE | As per Azure | |||
| CELEBREX 100MG HARD CAPS | 60CAPS | 17019 | 1st December 2026 | VIATRIS | 13-Jul-26 | 22-Jul-26 | Unexpected increased demand | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELEBREX 200MG HARD CAPS | 30CAPS | 17066 | 15th December 2026 | VIATRIS | 03-Aug-26 | 17-Aug-26 | Unexpected increased demand | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELECOXIB 200MG HARD CAPS | 30CAPS | 13407 | 31st December 2026 | ACCORD HC | 04-Feb-26 | 14-Oct-26 | Manufacturing delay | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELECOXIB KRKA 200MG HARD CAPS | 30CAPS | 13409 | In Stock | KRKA PHARM | 22-Jul-26 | 27-Oct-26 | 27-Oct-26 | Unexpected increased demand | CELECOXIB | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CHLOROMYCETIN 0.5% REDI-DROPS EYE DROPS | 10ML | 67318 | No confirmed timeline | ADVANZ | 05-Aug-25 | 20-May-26 | Manufacturing issue | CHLORAMPHENICOL | As per Advanz | EMP reimbursed for duration of HPRA registered shortage | |
| CINACALCET ACCORDPHARMA 30MG FC TABS | 28TABS | 89046 | TBC | ACCORD HC | 21-Mar-25 | 20-May-26 | Manufacturing delay | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET ACCORDPHARMA 60MG FC TABS | 28TABS | 89047 | TBC | ACCORD HC | 21-Mar-25 | 20-May-26 | Manufacturing delay | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET ACCORDPHARMA 90MG FC TABS | 28TABS | 89048 | TBC | ACCORD HC | 14-Feb-25 | 20-May-26 | No reason provided | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET TEVA 60MG FC TABS | 28TABS | 89081 | Dec-26 | TEVA | 27-Jul-23 | 02-Oct-26 | No reason provided | CINACALCET | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET TEVA 90MG FC TABS | 28TABS | 89082 | Nov-26 | TEVA | 03-Aug-23 | 03-Sep-26 | No reason provided | CINACALCET | As per Teva. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPRAGER 10MG FC TABS CITALOPRAM | 28TABS | 18503 | 16th November 2026 | VIATRIS | 07-May-26 | 15-Sep-26 | Manufacturing delay | CITALOPRAM | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPRAGER 40MG FC TABS CITALOPRAM | 28TABS | 18345 | 16th November 2026 | VIATRIS | 07-May-26 | 08-Sep-26 | Manufacturing delay | CITALOPRAM | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPROFLOXACIN TEVA 500MG FC TABS | 10TABS | 18952 | TBC | TEVA | 21-Nov-24 | 20-May-26 | Capacity issues | CIPROFLOXACIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPROFLOXACIN TEVA 500MG FC TABS | 20TABS | 18974 | TBC | TEVA | 27-Feb-25 | 20-May-26 | No reason provided | CIPROFLOXACIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CITALOPRAM TEVA 20MG FC TABS | 28TABS | 17910 | OOS 30th October. Return date 4th December 2026 | TEVA | 16-Oct-26 | 28-Oct-26 | Manufacturing delay | CITALOPRAM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CITALOPRAM TEVA 40MG FC TABS | 28TABS | 17911 | Nov-26 | TEVA | 18-Sep-26 | 29-Oct-26 | Manufacturing delay | CITALOPRAM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLARITHROMYCIN TEVA 250MG FC TABS | 14TABS | 13002 | Jan-27 | TEVA | 04-Sep-26 | 08-Oct-26 | Manufacturing delay | CLARITHROMYCIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLARITHROMYCIN TEVA 500MG FC TABS | 14TABS | 13003 | Jan-27 | TEVA | 03-Aug-26 | 08-Oct-26 | Manufacturing delay | CLARITHROMYCIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLINDAMYCIN 150MG/ML SOLN/INJ 2ML POA | 5AMP | 1st December 2026 | FRES KABI | 26-Aug-26 | 19-Oct-26 | Manufacturing delay | CLINDAMYCIN | As per HPRA | |||
| CLINDAMYCIN 150MG/ML SOLN/INJ 4ML POA | 5AMP | 19th October 2026 | FRES KABI | 26-Aug-26 | 19-Oct-26 | Manufacturing delay | CLINDAMYCIN | As per HPRA | |||
| CLOBAZAM THAME 5MG/5ML ORAL SUSPENSION | 150ML | 67278 | 1st November 2026 | AZURE | 17-Aug-26 | 05-Oct-26 | Manufacturing delay | CLOBAZAM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLONACTIL 25MG FC TABS CHLORPROMAZINE | 250TABS | 17876 | Mid December 2026 | CLONMEL | 16-Sep-26 | 12-Oct-26 | Manufacturing delay | CHLORPROMAZINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLONFOLIC 0.4MG TABS | 28TABS | TBC | CLONMEL | 08-Jul-24 | 22-May-26 | Quality issue | FOLIC ACID | As per Clonmel | |||
| CLONFOLIC 0.4MG TABS | 98TABS | 18176 | TBC | CLONMEL | 05-Jul-24 | 22-May-26 | Quality issue | FOLIC ACID | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CO-AMOXICLAV TEVA 1000MG/200MG PDRINJINF | 10VIAL | TBC | TEVA | 18-Jun-26 | 31-Jul-26 | Manufacturing delay | CO-AMOXICLAV | As per Teva. Not expected before 2027 | |||
| CO-AMOXICLAV TEVA 500MG/100MG PDRINJINF | 10VIAL | TBC | TEVA | 08-Mar-24 | 22-Jan-26 | Unexpected increase in demand | CO-AMOXICLAV | As per Teva | |||
| COLOMYCIN 1 MIU PDR FOR SOLN/INJ/INF/INH | 10VIAL | 66036 | 15th January 2027 | TEVA | 05-Oct-26 | 27-Oct-26 | Manufacturing delay | COLISTIMETHATE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| COLOMYCIN 2 MIU PDR FOR SOLN/INJ/INF/INH | 10VIAL | 66035 | Nov-26 | TEVA | 17-Oct-26 | 29-Oct-26 | Manufacturing delay | COLISTIMETHATE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| COMBODART 0.5MG/0.4MG HARD CAPS | 30CAPS | 13987 | 1st December 2026 | GSK MED | 25-Aug-26 | 15-Sep-26 | Unexpected increased demand | DUTASTERIDE/TAMSULOSIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CORTIMENT 9MG PRO REL TABS | 30TABS | 36833 | 4th December 2026 | FERRING | 19-Oct-26 | 29-Oct-26 | Unexpected increased demand | BUDESONIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| COSENTYX 300MG SOLN/INJ PFP | 1PENS | 89092 | OOS expected 29th October. Return date 30th October 2026 | NOVARTIS | 23-Oct-26 | 28-Oct-26 | Manufacturing site issue | SECUKINUMAB | As per Novartis | ||
| CYTARABINE 100MG/ML SOLN/INJ 20ML POA | 1VIAL | 6th November 2026 | ACCORD HC | 11-Sep-26 | 06-Oct-26 | Shipping delay / distribution issue | CYTARABINE | As per HPRA | |||
| DALACIN C PHOS 150MG/ML CONC INJ/INF 2ML | 5AMP | 84786 | 14th December 2026 | PFIZER | 16-Oct-26 | 28-Oct-26 | Unexpected increased demand | CLINDAMYCIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEFERASIROX ACCORD 180MG FC TABS | 30TABS | 89165 | 15th December 2026 | ACCORD HC | 01-Oct-26 | 15-Oct-26 | Shipping delay / distribution issue | DEFERASIROX | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEPREGER 100MG FC TABS SERTRALINE | 28TABS | 20784 | No back in stock date available at the moment | VIATRIS | 22-Aug-24 | 20-May-26 | No reason provided | SERTRALINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEPREGER 50MG FC TABS SERTRALINE | 28TABS | 20713 | No back in stock date available at the moment | VIATRIS | 06-Nov-24 | 20-May-26 | No reason provided | SERTRALINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DESENEX POWDER | 55G | Early November 2026 | CLONMEL | 20-Jun-25 | 12-Oct-26 | Manufacturing delay | ZINC UNDECYL/UNDECYL ACID | As per Clonmel. | |||
| DESLOR 0.5MG/ML ORAL SOLN DESLORATADINE | 100ML | 35803 | 19th January 2027 | ROWA | 16-Oct-26 | 28-Oct-26 | Manufacturing delay | DESLORATADINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DESLOR 5MG FC TABS DESLORATADINE | 30TABS | 35715 | Back In Stock | ROWA | 18-Sep-26 | 19-Oct-26 | 16-Oct-26 | Unexpected increase in sales | DESLORATADINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DESOGESTREL ROWEX 75MCG FC TABS | 28TABS | 17963 | Return date TBC | ROWA | 07-Aug-26 | 18-Aug-26 | Increasein sales | DESOGESTREL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DESOGESTREL ROWEX 75MCG FC TABS | 84TABS | 33513 | Back In Stock | ROWA | 13-Aug-26 | 05-Oct-26 | 02-Oct-26 | Manufacturing delay | DESOGESTREL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DETRUSITOL 1MG FC TABS | 56TABS | 53615 | 16th November 2026 | VIATRIS | 31-Jul-26 | 23-Sep-26 | Unexpected increased demand | TOLTERODINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DETRUSITOL SR 2MG PRO REL HARD CAPS | 28CAPS | 53651 | Back In Stock | VIATRIS | 02-Sep-26 | 27-Oct-26 | 22-Oct-26 | Unexpected increased demand | TOLTERODINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DETRUSITOL SR 4MG PRO REL HARD CAPS | 28CAPS | 53662 | 23rd November 2026 | VIATRIS | 01-Oct-26 | 12-Oct-26 | Unexpected increased demand | TOLTERODINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEXAMETHASONE PHOS NORIDEM 4MG/ML 1ML | 10AMP | Awaiting update | CARAGEN | 01-Apr-26 | 27-Jul-26 | Manufacturing delay | DEXAMETHASONE PHOSPHATE | As per Caragen | |||
| DEXSOL 2MG/5ML ORAL SOLN DEXAMETHASONE | 150ML | 20639 | In Stock | ROSEMONT | 23-Sep-26 | 09-Oct-26 | 08-Oct-26 | Regulatory issue | DEXAMETHASONE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DIACLIDE MR 60MG MOD REL TABS GLICLAZIDE | 30TABS | 43777 | 15th February 2027 | VIATRIS | 01-Oct-26 | 05-Oct-26 | No reason provided | GLICLAZIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DICLAC 1% GEL DICLOFENAC | 50G | 22274 | 30th October 2026 | ROWA | 13-Aug-26 | 27-Oct-26 | Increase in sales | DICLOFENAC SODIUM | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DICLAC 50MG GAST RES TAB DICLOFENAC | 100TABS | 22233 | 31st October 2026 | ROWA | 02-Oct-26 | 15-Oct-26 | Unexpected increased demand | DICLOFENAC SODIUM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DIPRIVAN 1% EMUL/INJ/INF 50ML PFS | 1SYR | In Stock | ASPEN | 05-Jun-26 | 20-Oct-26 | 20-Oct-26 | Manufacturing delay | PROPOFOL | No longer on HPRA list | ||
| DIPROSALIC SCALP APPLICATION | 100ML | 21474 | In Stock | ORGANON | 07-Aug-26 | 09-Oct-26 | 08-Oct-26 | Manufacturing delay | BETAMETHASO DIPRO/SALICYL | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DONA 1500MG PDR FOR ORAL SOLN SACHET | 30SACH | In Stock | COOPER CH | 11-Jun-26 | 27-Oct-26 | 27-Oct-26 | Manufacturing delay | GLUCOSAMINE | No longer on HPRA list | ||
| DONEPEZIL TEVA 10MG FC TABS | 28TABS | 14750 | 26th February 2027 | TEVA | 25-Sep-26 | 12-Oct-26 | Manufacturing delay | DONEPEZIL | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DOXORUBICIN TEVA 2MG/ML CONC/INF 5ML | 1VIAL | TBC | TEVA | 17-Apr-25 | 26-Mar-26 | No reason provided | DOXORUBICIN | As per Teva | |||
| DOXYCYCLINE 100MG HARD CAPS | 8CAPS | 67434 | Pending | ATHLONE PH | 19-Aug-26 | 27-Oct-26 | Unexpected increased demand | DOXYCYCLINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE 30MG GAST RES CAPS | 28CAPS | 37031 | No return date | ACCORD HC | 16-Sep-24 | 18-Aug-26 | Quality issue | DULOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| DULOXETINE 60MG GAST RES CAPS | 28CAPS | 37032 | No return date | ACCORD HC | 20-Mar-24 | 20-May-26 | Quality issue | DULOXETINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE CLONMEL 30MG GAST RES CAPS | 28CAPS | 37023 | TBC | CLONMEL | 26-Jan-26 | 18-Aug-26 | No reason provided | DULOXETINE | As per Clonmel. | EMP reimbursed for duration of HPRA registered shortage | |
| DULOXETINE CLONMEL 60MG GAST RES CAPS | 28CAPS | 37034 | TBC | CLONMEL | 16-Dec-25 | 22-May-26 | No reason provided | DULOXETINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE KRKA 30MG GAST RES CAPS | 28CAPS | 36852 | OOS expected early November. Return date 8th March 2027 | KRKA PHARM | 18-Aug-26 | 27-Oct-26 | Unexepected increased demand | DULOXETINE | As per KRKA | EMP reimbursed for duration of HPRA registered shortage | |
| DULOXETINE PINEWOOD 30MG GAST RES CAPS | 28CAPS | 67235 | 15th October 2026 | PINEWOOD | 19-Aug-26 | 24-Aug-26 | Unexpected increased demand | DULOXETINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| DULOXETINE VIATRIS 30MG GAST RES CAPS | 28CAPS | 36818 | 1st April 2027 | VIATRIS | 31-Mar-26 | 18-Aug-26 | Quality issue | DULOXETINE | As per Viatris | EMP reimbursed for duration of HPRA registered shortage | |
| DULOXETINE VIATRIS 60MG GAST RES CAPS | 28CAPS | 36819 | 1st April 2027 | VIATRIS | 27-Apr-26 | 20-May-26 | Quality issue | DULOXETINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE ZENTIVA 30MG GAST RES CAPS | 28CAPS | 43034 | 19th October 2026 | ZENTIVA | 23-Sep-26 | 05-Oct-26 | No reason provided | DULOXETINE | As per Allphar | EMP reimbursed for duration of HPRA registered shortage | |
| DULOXETINE ZENTIVA 60MG GAST RES CAPS | 28CAPS | 43035 | Back In Stock | ZENTIVA | 23-Sep-26 | 07-Oct-26 | 07-Oct-26 | No reason provided | DULOXETINE | As per Allphar | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DUROGESIC DTRANS 12MCG/HR PATCH | 5PATCH | 73228 | OOS expected 30th October. Return date 9th November 2026 | JANSSEN | 16-Oct-26 | 28-Oct-26 | Manufacturing delay | FENTANYL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE 0.5MG SOFT CAPS | 30CAPS | 54320 | Nov-26 | TEVA | 30-Mar-26 | 17-Sep-26 | Unexpected increased demand | DUTASTERIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE ROWA 0.5MG SOFT CAPS | 30CAPS | 54327 | Back In Stock | ROWA | 14-May-26 | 19-Oct-26 | 16-Oct-26 | Increase in sales | DUTASTERIDE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DUTASTERIDE/TAMSULO ROWA 0.5/0.4MG CAPS | 30CAPS | 54303 | Back In Stock | ROWA | 04-Mar-26 | 19-Oct-26 | 16-Oct-26 | Unprecedented demand | DUTASTERIDE/TAMSULOSIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| E45 CREAM PUMP | 500G | 16th November 2026 | KARO | 31-Jul-26 | 15-Oct-26 | Manufacturer cannot supply | EMOLLIENT | As per HPRA | |||
| EDRONAX 4MG TABS | 60TABS | 22861 | 9th November 2026 | PFIZER | 04-Aug-26 | 17-Aug-26 | Manufacturing delay | REBOXETINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ELTROMBOPAG TEVA 50MG FC TABS | 28TABS | 89480 | Back In Stock | TEVA | 24-Sep-26 | 08-Oct-26 | 08-Oct-26 | No reason provided | ELTROMBOPAG | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ENTECAVIR ACCORD 0.5MG FC TABS | 30TABS | 88986 | Pending | ACCORD HC | 17-Sep-26 | 02-Oct-26 | Shipping delay / distribution issue | ENTECAVIR | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ENTECAVIR ROWEX 0.5MG FC TABS | 30TABS | 88878 | 15th January 2027 | ROWA | 02-Oct-26 | 15-Oct-26 | Manufacturing delay | ENTECAVIR | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ENTECAVIR VIATRIS 0.5MG FC TABS | 30TABS | 88189 | 14th December 2026 | VIATRIS | 20-Jul-26 | 07-Oct-26 | Manufacturing delay | ENTECAVIR | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPILIM CHRONO 200MG PRO REL TABS | 30TABS | 37038 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONO 300MG PRO REL TABS | 30TABS | 37039 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONOSPHERE 100MG PRO REL GRAN | 30SACH | 23503 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONOSPHERE 250MG PRO REL GRAN | 30SACH | 23516 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONOSPHERE 500MG PRO REL GRAN | 30SACH | 23524 | Back In Stock | SANOFI AVE | 22-Sep-26 | 27-Oct-26 | 27-Oct-26 | Manufacturing delay | VALPROATE | As per Sanofi | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| EPIPEN JUNIOR 150MCG SOLN FOR INJ PFP | 2PENS | 15928 | 16th November 2026 | VIATRIS | 22-Sep-26 | 05-Oct-26 | Manufacturing delay | EPINEPHRINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPORATIO 1000 IU/0.5ML SOLN FOR INJ PFS | 6SYR | 88474 | 27th November 2026 | TEVA | 28-Sep-26 | 12-Oct-26 | Manufacturing delay | EPOETIN THETA | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ERELZI 50MG SOLN FOR INJ PFP | 4PENS | 89170 | In Stock | SANDOZ | 19-Oct-26 | 29-Oct-26 | 28-Oct-26 | Shipping delay / distribution issue | ETANERCEPT | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ERYTHROCIN 500MG TABS | 100TABS | 64076 | No confirmed resupply timeline at present, | ADVANZ | 20-Mar-26 | 08-Jul-26 | Manufacturing issue | ERYTHROMYCIN | As per Advanz | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ERYTHROCIN LACTOBIONATE 1G PDR CONC INF | 1VIAL | 82627 | No confirmed resupply timeline. | ADVANZ | 05-Jun-26 | 04-Aug-26 | Ongoing manufacturing issue | ERYTHROMYCIN | As per Advanz. HPRA-approved BSR stock is available for hospitals. Please contact Advanz customer care team to place an order. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESCITALPRO 10MG FC TABS ESCITALOPRAM | 28TABS | 13124 | 15th December 2026 | VIATRIS | 28-Sep-26 | 12-Oct-26 | Unexpected increased demand | ESCITALOPRAM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESCITALPRO 15MG FC TABS ESCITALOPRAM | 28TABS | 13125 | Jan-27 | VIATRIS | 16-Mar-26 | 07-Oct-26 | Manufacturing delay | ESCITALOPRAM | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESCITALPRO 20MG FC TABS ESCITALOPRAM | 28TABS | 13128 | 15th January 2027 | VIATRIS | 09-Sep-26 | 14-Oct-26 | Unexpected increased demand | ESCITALOPRAM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESCITALPRO 5MG FC TABS ESCITALOPRAM | 28TABS | 13122 | Pending | VIATRIS | 09-Sep-26 | 15-Sep-26 | Unexpected increased demand | ESCITALOPRAM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESOMEPRAZOLE TILLO 40MG PDR SOLN/INJ/INF | 10VIAL | 1st December 2026 | AZURE | 01-May-26 | 17-Jun-26 | No reason provided | ESOMEPRAZOLE | As per HPRA | |||
| ESTRADIOL SUN 10MCG VAGINAL TABS | 24vagtab | 67170 | Pending | PINEWOOD | 28-Oct-26 | Unexpected increased demand | ESTRADIOL | As per HPRA | |||
| ESTRADOT 100MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 47415 | TBC (on allocation when in stock) | SANDOZ | 27-Mar-26 | 09-Sep-26 | Limited stock | ESTRADIOL | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| ESTRADOT 37.5MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 68314 | TBC | SANDOZ | 16-Apr-26 | 09-Sep-26 | No reason provided | ESTRADIOL | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| ESTRADOT 75MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 48323 | Pending | SANDOZ | 27-Oct-26 | No reason provided | ESTRADIOL | As per HPRA | |||
| ETALOPRO 20MG FC TABS ESCITALOPRAM | 28TABS | 13150 | Mid December 2026 | CLONMEL | 01-Oct-26 | 12-Oct-26 | Unexpected increased demand | ESCITALOPRAM | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB 30MG FC TABS | 28TABS | 36842 | 4th January 2027 | VIATRIS | 30-Jul-26 | 05-Aug-26 | No reason provided. Short since 13th July | ETORICOXIB | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB 90MG FC TABS | 28TABS | 36855 | 1st November 2026 | VIATRIS | 02-Sep-26 | 07-Sep-26 | Manufacturing delay | ETORICOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB KRKA 30MG FC TABS | 28TABS | 36796 | 7th January 2027 | KRKA PHARM | 24-Sep-26 | 27-Oct-26 | Unexpected increased demand | ETORICOXIB | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB TEVA 120MG FC TABS | 28TABS | 36887 | Nov-26 | TEVA | 18-Sep-26 | 29-Oct-26 | Manufacturing delay | ETORICOXIB | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB TEVA 30MG FC TABS | 28TABS | 36884 | TBC | TEVA | 24-Nov-25 | 15-Oct-26 | Manufacturing delay | ETORICOXIB | As per Teva. HPRA shows 28th February 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EUCARDIC 6.25MG TABS | 28TABS | 24233 | 25th October 2026 | ATHENA | 28-Sep-26 | 05-Oct-26 | Shipping delay / distribution issue | CARVEDILOL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EUMOVATE 0.05% CREAM | 30G | 23116 | 16th November 2026 | GSK MED | 29-Sep-26 | 12-Oct-26 | Unexpected increased demand | CLOBETASONE BUTYRATE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| EVOREL 50MCG/24HR TRANSDERMAL PATCH | 8PATCH | 24425 | In Stock | THERAMX IR | 07-Oct-26 | 12-Oct-26 | 12-Oct-26 | Unexpected increased demand | ESTRADIOL | No longer on HPRA list | |
| EZETIMIBE 10MG TABS | 28TABS | 36760 | 30th November 2026 | ACCORD HC | 19-Oct-26 | 28-Oct-26 | Unexpected increased demand | EZETIMIBE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETIMIBE 10MG TABS | 28TABS | 36871 | Dec-26 | VIATRIS | 17-Jun-26 | 07-Oct-26 | Manufacturing delay | EZETIMIBE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETIMIBE KRKA 10MG TABS | 28TABS | 36773 | In Stock | KRKA PHARM | 28-Sep-26 | 27-Oct-26 | 27-Oct-26 | No reason provided | EZETIMIBE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| EZETIMIBE ROWA 10MG TABS | 28TABS | 36888 | End October 2026 (ETA) | ROWA | 18-Sep-26 | 05-Oct-26 | Unanticipated demand | EZETIMIBE | As per Rowa EMP Ezetimibe will be available early w/c 5th Oct | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETROL 10MG TABS IMED | 30TABS | 67078 | No return date (28 pack available) | IMED | 20-Jan-26 | 15-Sep-26 | Europe wide shortage | EZETIMIBE | As per IMED | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETROL 10MG TABS PCO | 28TABS | 23275 | Ongoing intermittent supply. | PCO | 20-Jan-26 | 15-Jul-26 | No reason provided | EZETIMIBE | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FAMOTIDINE CLONMEL 40MG FC TABS | 30TABS | 44453 | End October 2026 | CLONMEL | 16-Sep-26 | 28-Sep-26 | No reason provided | FAMOTIDINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FASLODEX 250MGSOLN FOR INJ PFS PCO | 2SYR | 88793 | No return to stock date | PCO | 20-Apr-26 | 08-Jul-26 | Unable to source stock at a workable price | FULVESTRANT | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FE CARBOXYMALT 50MG/ML DISP/INJ/INF 20ML | 1VIAL | Awaiting confirmation of delivery | ROWEX | 17-Jul-26 | 05-Oct-26 | Delayed delivery | FERRIC CARBOXYMALTOSE | As per Rowa | |||
| FEBUXOSTAT ROWEX 120MG FC TABS | 28TABS | 24705 | 22nd February 2027 | ROWA | 16-Oct-26 | 28-Oct-26 | Manufacturing constraints | FEBUXOSTAT | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FESOTERODINE CLONMEL 8MG PRO REL TABS | 30TABS | 66935 | End October 2026 | CLONMEL | 16-Sep-26 | 12-Oct-26 | No reason provided | FESOTERODINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FINGOLIMOD CLONMEL 0.5MG HARD CAPS | 28CAPS | 89398 | Early November 2026 | CLONMEL | 19-Dec-25 | 12-Oct-26 | Manufacturing delay | FINGOLIMOD | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLAGYL-S 200MG/5ML ORAL SUSP | 100ML | 25666 | 16th February 2027 | FIDIA | 02-Oct-26 | 15-Oct-26 | Unexpected increased demand | METRONIDAZOLE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLECAINIDE 100MG TABS | 60TABS | 26080 | Back In Stock | TEVA | 05-Sep-25 | 08-Oct-26 | 08-Oct-26 | Awaiting release | FLECAINIDE | As per Teva. | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| FLECAINIDE 50MG TABS | 60TABS | 26072 | Back In Stock | TEVA | 06-May-25 | 08-Oct-26 | 08-Oct-26 | Awaiting release | FLECAINIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| FLUCILLIN 250MG CAPS FLUCLOXACILLIN | 100CAPS | 25194 | Back In Stock | PINEWOOD | 08-Oct-25 | 09-Oct-26 | 09-Oct-26 | Manufacturing delay | FLUCLOXACILLIN | As per Pinewood | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| FLUCILLIN 250MG CAPS FLUCLOXACILLIN | 500CAPS | 24821 | No return date | PINEWOOD | 08-Oct-25 | 17-Sep-26 | Manufacturing delay | FLUCLOXACILLIN | As per Pinewood | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLUCONAZOLE 200MG HARD CAPS | 7CAPS | 25107 | 15th January 2027 | ACCORD HC | 19-Oct-26 | 28-Oct-26 | Manufacturing delay | FLUCONAZOLE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FOLIC ACID 5MG TABS | 56TABS | 25805 | Early December 2026 | CLONMEL | 07-Jul-26 | 31-Aug-26 | No reason provided | FOLIC ACID | As per Clonmel. Temp code 55568 (28 pack) eff 01.09.26 | Temporay code 55568 effective from 1st September 2026 | |
| FOLINIC ACID 10MG/ML SOLN/INJ/INF 50ML | 1VIAL | Awaiting update | CARAGEN | 05-Dec-25 | 27-Jul-26 | No reason provided | FOLINIC ACID | As per Caragen | |||
| FUCITHALMIC 10MG/G VISCOUS EYE DROP SUSP | 5G | 26441 | No confirmed timeline | ADVANZ | 13-Sep-19 | 13-Oct-26 | Long term manufacturing issue | FUSIDIC ACID | Contact Advanz Customer Service 1890 252 474 for further info. HPRA shows 21.09.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FULVESTRANT TEVA 250MG/5ML SOLN/INJ PFS | 2SYR | 89054 | Nov-26 | TEVA PHARM | 17-Aug-26 | 03-Sep-26 | Manufacturing delay | FULVESTRANT | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FUROSEMIDE 20MG TABS | 100TABS | 74543 | TBC | CLONMEL | 19-Aug-26 | 16-Sep-26 | Manufacturing delay | FUROSEMIDE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| FUROSEMIDE 40MG TABS | 500TABS | 74551 | TBC | CLONMEL | 22-May-26 | 16-Sep-26 | No reason provided | FUROSEMIDE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| FUROSEMIDE PINEWOOD 40MG TABS | 100TABS | 67297 | Mid-end October 2026 | PINEWOOD | 01-Sep-26 | 12-Oct-26 | Awaiting QA testing & QP release | FUROSEMIDE | As per Pinewood | EMP reimbursed for duration of HPRA registered shortage | |
| GABIN 100MG HARD CAPS GABAPENTIN | 100CAPS | 76704 | December 2026 (ETA) | ROWA | 18-Sep-26 | 28-Sep-26 | Manufacturing delay | GABAPENTIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GABIN 300MG CAPS GABAPENTIN | 100CAPS | 76720 | Mid November 2026 | ROWA | 30-Jul-26 | 19-Oct-26 | Manufacturing delay | GABAPENTIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GADOVIST 1.0MMOL/ML SOLN/INJ 15ML PFS | 1SYR | In Stock | BAYER | 22-Sep-26 | 27-Oct-26 | 27-Oct-26 | Unexpected increased demand | GADOBUTROL | No longer on HPRA list | ||
| GAMANIL 70MG TABS | 56TABS | 25143 | Jan-28 | ZENTIVA | 18-Dec-23 | 21-Aug-26 | Very complex product transfer resulting in a number of delays. | LOFEPRAMINE | As per Zentiva. HPRA shows 30th November 2026 return date | EMP reimbursed for duration of HPRA registered shortage | |
| GASTROGRAFIN ORAL AND RECTAL SOLUTION | 100ML | 2027 | BAYER | 10-Mar-26 | 30-Sep-26 | Quality issue | SOD AMIDOTRI/MEGLUM AMIDO | As per Bayer | |||
| GAVISCON EXTRA CHEWABLE TABS | 24TABS | In Stock | RECKITTS | 24-Aug-26 | 06-Oct-26 | 06-Oct-26 | Manufacturing delay | SOD ALG/SOD H CARB/CACARB | No longer on HPRA | ||
| GEODON 80MG HARD CAPS | 60CAPS | 36018 | Back In Stock | VIATRIS | 07-May-26 | 12-Oct-26 | 12-Oct-26 | Manufacturing delay | ZIPRASIDONE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| GLUCOSE IV 10% SOLN FOR INF 500ML | 1BOTTLE | In Stock | B BRAUN | 25-Sep-26 | 06-Oct-26 | 06-Oct-26 | Unexpected increased demand | GLUCOSE | No longer on HPRA list | ||
| GLYCEROL SUPPOSITORIES BP FOR ADULTS | 12SUPPOS | 15th January 2027 | FANNIN | 19-Oct-26 | 20-Oct-26 | Quality issue | GLYCEROL | As per HPRA | |||
| GOLDEN EYE 0.15% OINTMENT | 5G | Jan-27 | CAM HC SUP | 29-Aug-25 | 06-Oct-25 | Manufacturing delays | DIBROMPROPAMIDINE | As per HPRA | |||
| GREPID 75MG FC TABS CLOPIDOGREL | 28TABS | 27519 | w/c 12th October 2026 | PHARMATHEN | 20-Mar-25 | 17-Sep-26 | Shipping delay / distribution issue | CLOPIDOGREL | As per Pinewood | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| HALCION 0.125MG TABS | 30TABS | 27340 | Back In Stock | PFIZER | 14-Sep-26 | 19-Oct-26 | 16-Oct-26 | Shipping delay / distribution issue | TRIAZOLAM | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| HYPOVASE 0.5MG TABS | 60TABS | 28570 | 16th November 2026 | PFIZER | 12-Oct-26 | 28-Oct-26 | Manufacturing delay | PRAZOSIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IBANDRONIC ACID MYLAN 150MG FC TABS | 1TABS | 14041 | Jan-27 | VIATRIS | 03-Sep-25 | 04-Sep-26 | Unexpected increased demand | IBANDRONIC ACID | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IBANDRONIC ACID TEVA 150MG FC TABS | 1TABS | 16130 | Discontinued | TEVA | 07-Dec-23 | 27-Oct-26 | 22-Oct-26 | No reason provided | IBANDRONIC ACID | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| IBUPROFEN 200MG FC TABS | 100TABS | 67172 | Awaiting return date | ACCORD HC | 16-Apr-26 | 20-May-26 | Manufacturing delay | IBUPROFEN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ICATIBANT ACCORD 30MG SOLN/INJ PFS | 1SYR | 89122 | Pending | ACCORD HC | 01-Oct-26 | 15-Oct-26 | Manufacturing delay | ICATIBANT | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IKERVIS 1MG/ML EYE DROPS EMULSION SDU | 30UDV | 30735 | 16th November 2026 | SANTEN | 22-Sep-26 | 05-Oct-26 | Unexpected increased demand | CICLOSPORIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IMDUR 60MG PRO REL TABS | 28TABS | 31410 | Pending | NAVAMEDIC | 29-Sep-23 | 30-Jul-26 | Unexpected increase in demand | ISOSORBIDE MONONITRATE | As per HPRA 30.07.26 Navamedic advised they have no estimate of re-supply date for Imdur in Ireland | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IMUGER 25MG FC TABS AZATHIOPRINE | 100TABS | 59303 | 2nd November 2026 | VIATRIS | 31-Jul-26 | 17-Aug-26 | Unexpected increased demand | AZATHIOPRINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IMULDOSA 130MG CONC FOR SOLN INF 26ML | 1VIAL | No return date | ACCORD HC | 16-Jun-26 | 30-Jul-26 | Unexpected increased demand | USTEKINUMAB | As per Accord | |||
| INFLUVAC FLU VACCINE PFS 2026-2027 | 1SYR | 1st September 2027 | VIATRIS | 16-Sep-26 | Manufacturing delay | TRIVALENT FLU VACCINE | As per HPRA | ||||
| INNOHEP 4500 IU SOLN/INJ PFS | 10SYR | 27042 | 13th November 2026 | LEO PHARMA | 16-Oct-26 | 29-Oct-26 | Manufacturing delay | TINZAPARIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL LEVEMIR FLEXPEN 100 UNITS/ML BMODE | 5PENS | 67213 | Awaiting update | BMODESTO | 12-Mar-26 | 08-Jul-26 | Company trying to source supply | INSULIN DETEMIR | As per BModesto | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL LEVEMIR PENFILL100 UNIT/ML CTG PCO | 5CARTRIDG | 63005 | Limited stock due (as at 15.07.26) | PCO | 23-Jan-26 | 15-Jul-26 | PCO have had no supply for several months | INSULIN DETEMIR | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL NOVORAPID PENFILL 100 U/ML CTG | 5CARTRIDG | 63121 | On Allocation | NOVO NRDSK | 06-Mar-20 | 08-Jul-26 | INSULIN ASPART | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| IRINOTECAN HCL 20MG/ML CONC/SOL/INF 25ML | 1VIAL | Back In Stock | TEVA | 18-Aug-26 | 29-Oct-26 | 29-Oct-26 | Awaiting release | IRINOTECAN | As per Teva | ||
| IVABRADINE KRKA 5MG FC TABS | 56TABS | 42790 | 31st October 2026 | KRKA PHARM | 26-Aug-26 | 31-Aug-26 | No reason provided | IVABRADINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IVABRADINE ROWEX 5MG FC TABS | 56TABS | 42795 | Early 2027 | ROWA | 30-Jul-26 | 19-Oct-26 | Manufacturing dealy | IVABRADINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IVABRADINE ROWEX 7.5MG FC TABS | 56TABS | 42796 | TBC | ROWA | 30-Jul-26 | 05-Oct-26 | Manufacturing delay | IVABRADINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| KAY-CEE-L 7.5% SYRUP | 500ML | 29769 | Awaiting update | SYRI PHARM | 04-Mar-24 | 20-May-26 | Currently under testing and regulatory approval | POTASSIUM CHLORIDE | As per Syri Pharma | EMP reimbursed for duration of HPRA registered shortage | |
| KLACID PAED 125MG/5ML GRANS/ORAL SUSP | 100ML | 92037 | OOS expected 2nd November. Return date 5th April 2027 | VIATRIS | 26-Oct-26 | Manufacturing delay | CLARITHROMYCIN | As per HPRA | |||
| KONAKION MM 10MG/ML SOLN/INJ & ORAL SOLN | 10AMP | 3rd November 2026 | ATHENA | 08-Oct-26 | 30-Oct-26 | Unexpected increased demand | PHYTOMENADIONE | As per HPRA | |||
| LAMISIL ONCE 1% CUTANEOUS SOLN | 4G | Awaiting update | KARO | 31-Jul-26 | 11-Sep-26 | Manufacturer cannot supply | TERBINAFINE | As per UD | |||
| LARIG 50MG DISP TABS LAMOTRIGINE | 56TABS | 30641 | 16th November 2026 | ROWA | 16-Oct-26 | 28-Oct-26 | Manufacturing constraints | LAMOTRIGINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LAXIDO PAED PLAIN 6.9G PDR ORAL SOLN | 30SACH | 31606 | 9th November 2026 | GALEN | 09-Oct-26 | 19-Oct-26 | Unexpected increased demand | MACROGOL 3350 | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LECALPIN 10MG FC TABS LERCANIDIPINE | 28TABS | 26004 | 1st December 2026 | ACCORD HC | 27-Aug-26 | 08-Sep-26 | Unexpected increased demand | LERCANIDIPINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LENALIDOMIDE ACCORD 20MG HARD CAPS | 21CAPS | 89114 | 30th November 2026 | ACCORD HC | 19-Oct-26 | 28-Oct-26 | Manufacturing delay | LENALIDOMIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LENALIDOMIDE ACCORD 25MG HARD CAPS | 21CAPS | 89115 | 30th November 2026 | ACCORD HC | 19-Oct-26 | 28-Oct-26 | Manufacturing delay | LENALIDOMIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LENZETTO 1.53MG/SPRAY TRANSDERMAL SPRAY | 1SPY | 78085 | 9th November 2026 | GEDEON RCH | 03-Aug-26 | 30-Oct-26 | Unexpected increased demand | ESTRADIOL HEMIHYDRATE | As per HPRA. | EMP reimbursed for duration of HPRA registered shortage. Claims can be submitted under the Drugs Payment Scheme using code 77791. | |
| LEVOBUPIVACAINE 1.25MG/ML SOL/INF 100ML | 5BAG | Back In Stock | FRES KABI | 02-Oct-26 | 13-Oct-26 | 13-Oct-26 | No reason provided | LEVOBUPIVACAINE | As per Allphar | ||
| LIPITOR 10MG FC TABS | 28TABS | 31892 | Back In Stock | VIATRIS | 01-Oct-26 | 27-Oct-26 | 21-Oct-26 | Manufacturing delay | ATORVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| LIPITOR 80MG FC TABS | 28TABS | 32001 | 16th January 2027 | VIATRIS | 01-Oct-26 | 05-Oct-26 | Manufacturing delay | ATORVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LONITEN 5MG TABS | 60TABS | 77213 | 23rd November 2026 | PFIZER | 25-Sep-26 | 27-Oct-26 | Manufacturing delay | MINOXIDIL | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| LONQUEX 6MG/0.6ML SOLN FOR INJ | 1VIAL | 89416 | TBC | TEVA | 04-Jun-26 | 17-Sep-26 | No reason provided | LIPEGFILGRASTIM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LYCLEAR 5% DERMAL CREAM | 30G | 32292 | On Allocation | GSK MED | 03-May-24 | 20-May-26 | Supply constrained due to increased demand | PERMETHRIN | As per GSK | EMP reimbursed for duration of HPRA registered shortage | |
| LYRICA 50MG HARD CAPS | 84CAPS | 32241 | Early January 2027 | VIATRIS | 17-Jun-26 | 07-Oct-26 | Manufacturing delay | PREGABALIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MALARONE 250MG/100MG TABS | 12TABS | 32590 | In Stock | GSK MED | 01-Oct-26 | 20-Oct-26 | 20-Oct-26 | Quality issue | ATOVAQUONE/PROGUANIL | No longer on HPRA list | EMP reimbursed for duration of HPRA registered shortage |
| MEFAC 500MG FC TABS MEFENAMIC ACID | 100TABS | 32999 | Pending | ROWA | 08-Jun-26 | 05-Oct-26 | Unexpected increased demand | MEFENAMIC ACID | As per Rowa. Quality complaint on going, stock quarantined at CMO site, will update once decision is known | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MEGACE 160MG TABS | 30TABS | 33472 | 15th October 2026 | BAUSCH HEA | 18-Mar-26 | 18-Sep-26 | Manufacturing delay | MEGESTROL | As per Uniphar. EMP avail. HPRA shows 31.10.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MEMANTINE CLONMEL 10MG FC TABS | 28TABS | 30852 | OOS expected 2nd November. Return date 1st January 2027 | CLONMEL | 27-Oct-26 | Manufacturing delay | MEMANTINE | As per HPRA | |||
| MEMANTINE CLONMEL 10MG FC TABS | 56TABS | 31123 | OOS expected 2nd November. Return date 1st January 2027 | CLONMEL | 27-Oct-26 | Manufacturing delay | MEMANTINE | As per HPRA | |||
| MENTHOLATUM DEEP HEAT SPRY CUT SPRAY SOL | 150ML | 30th June 2027 | MENTHOLATM | 08-Jan-25 | 16-Jun-26 | Manufacturing delay | As per HPRA | ||||
| MEROPENEM AUROBINDO 1G PDR/SOLN/INJ/INF | 10VIAL | No return date at present | ATHLONE PH | 15-Jan-26 | 09-Sep-26 | Manufacturer cannot supply | MEROPENEM | As per Athlone. | |||
| METHOFILL 15MG SOLN/INJ PFI | 1INJTR | 35012 | 10th January 2027 | ACCORD HC | 16-Sep-26 | 23-Sep-26 | Manufacturing delay | METHOTREXATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MIDAZOLAM ROWA OROMUC SOLN 2.5MG PFS | 4SYR | 67163 | 29th October 2026 | ROWA | 18-Sep-26 | 05-Oct-26 | Manufacturing delay | MIDAZOLAM | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MIDODRINE TILLOMED 2.5MG TABS | 100TABS | 66964 | OOS expected 30th October. Return date 7th November 2026 | AZURE | 20-Oct-26 | No reason provided | MIDODRINE | As per HPRA | |||
| MIDON 2.5MG TABS | 100TABS | 34444 | 30th November 2026 | ATHENA | 19-May-26 | 10-Jun-26 | Unexpected increased demand | MIDODRINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MIDON 5MG TABS | 100TABS | 34436 | 22nd December 2026 | ATHENA | 28-Sep-26 | 05-Oct-26 | Unexpected increased demand | MIDODRINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MINIMS ATROPINE SULFATE 1% EYE DROPS | 20UDV | Pending | BAUSCH&L | 19-Oct-26 | Manufacturing delay | ATROPINE SULFATE | As per HPRA | ||||
| MINIMS CYCLOPENTOLATE HCL 1% EYE DROPS | 20UDV | 34061 | Pending | BAUSCH&L | 19-Oct-26 | 28-Oct-26 | Manufacturing delay | CYCLOPENTOLATE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| MINIMS PROXYMETACAINE 0.5% EYE DROPS | 20UDV | Pending | BAUSCH&L | 19-Oct-26 | Manufacturing delay | PROXYMETACAINE | As per HPRA | ||||
| MINIMS TETRACAINE HCL 1% EYE DROP SOLN | 20UDV | 34074 | Pending | BAUSCH&L | 19-Oct-26 | 28-Oct-26 | Manufacturing delay | TETRACAINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MINIMS TROPICAMIDE 1% EYE DROPS SOLN | 20UDV | Pending | BAUSCH&L | 28-Oct-26 | Manufacturing delay | TROPICAMIDE | As per HPRA | ||||
| MIRAP DISTAB 15MG ORODISP TABS MIRTAZAPI | 30TABS | 33549 | w/e 8th November 2026 | ROWA | 08-May-26 | 19-Oct-26 | Awaiting confirmation of next delivery Artwork needs to be finalised | MIRTAZAPINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MONTELUKAST PAEDIATRIC 5MG CHEWABLE TABS | 28TABS | 45131 | TBC | ACCORD HC | 12-Mar-26 | 20-May-26 | Manufacturing delay | MONTELUKAST | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MONTELUKAST VIATRIS 5MG CHEWABLE TABS | 28TABS | 45116 | No return date at present | VIATRIS | 17-Jun-26 | 06-Jul-26 | Manufacturing delay | MONTELUKAST | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MORPHINE SULPHATE 30MG/ML SOLN/INJ 1ML | 10AMP | 31st October 2026 | CARAGEN | 29-May-25 | 02-Sep-26 | No reason provided | MORPHINE SULFATE | As per Caragen | |||
| MOVICOL PAED PLAIN 6.9G PDR OR SOLN SACH | 30SACH | 34528 | 16th January 2027 | NORGINE | 03-Jul-26 | 16-Sep-26 | Quality issue | MACROGOL 3350 | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MOVIPREP POWDER FOR ORAL SOLUTION | 4SACH | 11th January 2027 | NORGINE | 30-Jul-26 | 14-Sep-26 | Quality issue | MACROGOL 3350 | As per HPRA | |||
| MURINE IRRITATION & RED RELIEF EYE DROPS | 10ML | 4th January 2027 | PRESTIGE | 13-Oct-26 | No reason provided | NAPHAZOLINE | As per HPRA. Short since 2024 | ||||
| MYCOBUTIN 150MG CAPS | 30CAPS | 64723 | Pending | PFIZER | 27-Apr-26 | 23-Sep-26 | API shortage / unavailability | RIFABUTIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MYCOPHENOLATE MOFETIL ACCORD 250MG CAPS | 100CAPS | 88858 | In Stock | ACCORD HC | 17-Jun-26 | 15-Oct-26 | 15-Oct-26 | Shipping delay / distribution issue | MYCOPHENOLATE | No longer on HPRAlist | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| NAUDICELLE PLUS CAPS | 336CAPS | 35483 | February 2027 (tentative) | BIO OIL | 30-Jun-26 | 09-Sep-26 | Manufacturing issue | EVENING PRIM/MARINE/TOCOP | As per Uniphar | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEUPRO 3MG/24HR TRANSDERMAL PATCH | 28PATCH | 44529 | 30th October 2026 | UCB PHARMA | 09-Oct-26 | 27-Oct-26 | Unexpected increased demand | ROTIGOTINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEURONTIN 100MG HARD CAPS | 100CAPS | 36269 | 9th November 2026 | VIATRIS | 17-Jul-26 | 31-Jul-26 | Unexpected increased demand. | GABAPENTIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEURONTIN 300MG HARD CAPS | 100CAPS | 36390 | In Stock | VIATRIS | 02-Sep-26 | 20-Oct-26 | 20-Oct-26 | Unexpected increased demand | GABAPENTIN | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| NEURONTIN 400MG HARD CAPS | 100CAPS | 36455 | OOS expected 2nd November. Return date 8th January 2027 | VIATRIS | 29-Oct-26 | Manufacturing delay | GABAPENTIN | As per HPRA | |||
| NEURONTIN 600MG FC TABS | 100TABS | 44539 | 9th November 2026 | VIATRIS | 29-Oct-26 | Manufacturing delay | GABAPENTIN | As per HPRA | |||
| NEUROSTIL 400MG CAPS HARD GABAPENTIN | 100CAPS | 36794 | Back In Stock (awaiting release) | TEVA | 25-Nov-25 | 27-Oct-26 | 27-Oct-26 | Manufacturing delay | GABAPENTIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| NIMBEX 2MG/ML SOLN FOR INJ/INF 2.5ML | 5AMP | No return date at present | ASPEN | 27-Apr-26 | 08-Sep-26 | Quality issue | CISATRACURIUM | As per Aspen | |||
| NIPENT 10MG PDR FOR SOLN/INJ/INF | 1VIAL | 1st April 2027 | PFIZER | 05-Oct-26 | 19-Oct-26 | Manufacturing delay | PENTOSTATIN | As per HPRA | |||
| NOQTURINA 50MCG ORAL LYOPHILISATE | 30TABS | 36969 | 14th November 2026 | FERRING | 14-Oct-26 | 27-Oct-26 | Unexpected increased demand | DESMOPRESSIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NORADRENALINE 1:1000 CONC/SOLN/INF 2ML | 5AMP | 9th November 2026 | PFIZER | 21-Apr-26 | 07-Aug-26 | Manufacturing delay | NOREPINEPHRINE | As per HPRA | |||
| NOTIABOLFEN XL 150MG PRO REL TABS | 60TABS | 31787 | Oct-26 | ACCORD HC | 04-Feb-26 | 07-Aug-26 | Manufacturing delay | QUETIAPINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 200MG PRO REL TABS | 60TABS | 32632 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 300MG PRO REL TABS | 60TABS | 32743 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 400MG PRO REL TABS | 60TABS | 32796 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NU-SEALS 75MG GAST RES TABS | 100TABS | 18672 | No return date provided | ALLIANCE | 15-Sep-26 | 22-Sep-26 | Manufacturer cannot supply | ACETYLSALICYLIC ACID | As per UD | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE 7.5MG FC TABS | 56TABS | 32925 | Mid November 2026 | CLONMEL | 03-Jun-26 | 12-Oct-26 | Manufacturing delay | OLANZAPINE | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE ACCORD 7.5MG FC TABS | 28TABS | 42312 | OOS expected 6th November. Return date pending | ACCORD HC | 28-Oct-26 | Unexpected increased demand | OLANZAPINE | As per HPRA | |||
| OLANZAPINE ACCORD 7.5MG FC TABS | 56TABS | 42316 | OOS expected 6th November. Return date pending | ACCORD HC | 28-Oct-26 | Unexpected increased demand | OLANZAPINE | As per HPRA | |||
| OLANZAPINE VIATRIS 10MG FC TABS | 28TABS | 32953 | 30th April 2027 | VIATRIS | 16-Jun-26 | 11-Aug-26 | Manufacturing delay | OLANZAPINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE VIATRIS 5MG FC TABS | 28TABS | 32951 | 1st March 2027 | VIATRIS | 08-May-26 | 22-May-26 | Manufacturing delay | OLANZAPINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLMESARTAN MEDOXOMIL 10MG FC TABS | 28TABS | 37623 | Oct-26 | ACCORD HC | 22-Jul-25 | 07-Aug-26 | Unexpected increased demand | OLMESARTAN | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLMESARTAN/AMLODIPINE CLONMEL 40MG/10MG | 28TABS | 24960 | Early November 2026 | CLONMEL | 16-Sep-26 | 12-Oct-26 | No reason provided | OLMESARTAN/AMLODIPINE | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLMESARTAN/AMLODIPINE CLONMEL 40MG/5MG | 28TABS | 24956 | Mid November 2026 | CLONMEL | 25-Sep-26 | 05-Oct-26 | Unexpected increased denand | OLMESARTAN/AMLODIPINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLMESARTAN/AMLODIPINE HCTZ 40/5/12.5MG | 28TABS | 37403 | End October 2026 | CLONMEL | 16-Sep-26 | 12-Oct-26 | No reason provided | OLMESARTAN/AMLODIPIN/HCTZ | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ONDANSETRON 8MG FC TABS | 10TABS | 55361 | Nov-26 | TEVA | 11-Nov-25 | 17-Sep-26 | Manufacturing delay | ONDANSETRON | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OPDIVO 10MG/ML CONC FOR SOLN/INF 12ML | 1VIAL | In Stock | BMS PHARM | 30-Sep-26 | 13-Oct-26 | 13-Oct-26 | Unexpected increased demand | NIVOLUMAB | No longer on HPRA list | ||
| OPTICROM RX 2% W/V EYE DROPS SOLUTION | 10ML | 48596 | End December 2026 | CLONMEL | 17-Aug-26 | 12-Oct-26 | No reason provided | SODIUM CROMOGLICATE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OVITRELLE 250MCG SOLN FOR INJ PFP | 1PENS | 88404 | 6th November 2026 | MERCK | 07-Oct-26 | 29-Oct-26 | Manufacturing delay | CHORIOGONADOTROPIN ALFA | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OXALIPLATIN 5MG/ML CONC/SOLN/INF 10ML | 1VIAL | TBC | ACCORD HC | 13-Mar-26 | 27-Mar-26 | Manufacturing delay | OXALIPLATIN | As per Accord | |||
| OXYBUTYNIN HYDROCHLORIDE 2.5MG TABS | 84TABS | 32333 | Jan-27 | ACCORD HC | 26-Aug-26 | 15-Sep-26 | Shipping delay / distribution issue | OXYBUTYNIN | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| OXYBUTYNIN HYDROCHLORIDE 5MG TABS | 84TABS | 32334 | Dec-26 | ACCORD HC | 26-Jun-25 | 15-Sep-26 | Manufacturing delay | OXYBUTYNIN | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| OZALIN 2MG/ML ORAL SOLN SINGLE DOSE 5ML | 10AMP | 31st December 2027 | NORDICPHAR | 07-Apr-26 | Regulatory issue | MIDAZOLAM | As per HPRA | ||||
| PABRINEX IV HIGH POTENCY CONC/SOLN/INF | 12AMP | Pending | GRUNENTHAL | 07-May-24 | 22-Jul-26 | Manufacturing issues | VITAMIN B/VITAMIN C | As per HPRA | |||
| PALMEUX 100MG PRO REL SUSP FOR INJ PFS | 1SYR | 67003 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 150MG PRO REL SUSP FOR INJ PFS | 1SYR | 67004 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 50MG PRO REL SUSP FOR INJ PFS | 1SYR | 67001 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 25-Aug-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows 30/06/2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 75MG PRO REL SUSP FOR INJ PFS | 1SYR | 67002 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 25-Aug-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows 30/06/2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PARALIEF 500MG EFF TABS PARACETAMOL | 12TABS | TBC | CLONMEL | 11-May-26 | 22-May-26 | Manufacturing delay | PARACETAMOL | As per Clonmel | |||
| PARALIEF 500MG EFF TABS PARACETAMOL | 24TABS | TBC | CLONMEL | 12-May-26 | 28-Sep-26 | Manufacturing delay | PARACETAMOL | As per Clonmel | |||
| PAROX 10MG FC TABS PAROXETINE | 30TABS | 13415 | Early November 2026 | ROWA | 18-Sep-26 | 19-Oct-26 | Manufacturing delay | PAROXETINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PAROX 20MG TABS PAROXETINE | 30TABS | 40101 | Early November 2026 | ROWA | 18-Sep-26 | 19-Oct-26 | Manufacturing delay | PAROXETINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PEMETREXED ACCORD 25MG/ML CONC INF 34ML | 1VIAL | TBC | ACCORD HC | 06-Feb-26 | 27-Mar-26 | Manufacturing delay | PEMETREXED | As per Accord | |||
| PEMETREXED ACCORD 25MG/ML CONC INF 40ML | 1VIAL | Pending | ACCORD HC | 28-Oct-26 | Manufacturing delay | PEMETREXED | As per HPRA | ||||
| PENDREX 2MG TABS PERINDOPRIL | 30TABS | 76800 | TBC | ROWA | 19-Oct-26 | 28-Oct-26 | Delayed delivery | PERINDOPRIL ERBUMINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PENDREX 4MG TABS PERINDOPRIL | 30TABS | 76883 | 30th October 2026 | ROWA | 13-Aug-26 | 27-Oct-26 | Increase in sales | PERINDOPRIL ERBUMINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PENDREX 8MG TABS PERINDOPRIL | 30TABS | 76830 | 4th January 2027 | ROWA | 18-Sep-26 | 05-Oct-26 | Increase in sales | PERINDOPRIL ERBUMINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERDAMEL 1MG FC TABS RISPERIDONE | 60TABS | 39523 | Back In Stock | CLONMEL | 16-Jul-26 | 12-Oct-26 | 12-Oct-26 | API Shortage / unavailability | RISPERIDONE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| PERINDOPRIL ARGININE CLONMEL 10MG FC TAB | 30TABS | 67242 | Mid October 2026 | CLONMEL | 27-Jul-26 | 28-Sep-26 | API Shortage / unavailability | PERINDOPRIL ARGININE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL ARGININE CLONMEL 5MG FC TABS | 30TABS | 67241 | End October 2026 | CLONMEL | 13-Aug-26 | 28-Sep-26 | Manufacturing delay | PERINDOPRIL ARGININE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL KRKA 4MG TABS | 30TABS | 39103 | 13th November 2026 | KRKA PHARM | 17-Aug-26 | 29-Oct-26 | No reason provided | PERINDOPRIL ERBUMINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL KRKA 8MG TABS | 30TABS | 39104 | 3rd December 2026 | KRKA PHARM | 17-Aug-26 | 29-Oct-26 | No reason provided | PERINDOPRIL ERBUMINE | As per KRKA. HPRA shows 31.12.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL TOS/AMLODIPINE TEVA 5MG/5MG | 30TABS | 36844 | Nov-26 | TEVA | 23-Sep-26 | 15-Oct-26 | Manufacturing delay | PERINDOPRIL TOSIL/AMLODIP | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL TOS/INDAPAM TEVA 2.5/0.625MG | 30TABS | 39114 | Back In Stock | TEVA | 04-Jun-26 | 27-Oct-26 | 27-Oct-26 | No reason provided | PERINDOPRIL TOSIL/INDAPAM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| PERINDOPRIL TOSILATE TEVA 10MG FC TABS | 30TABS | 39110 | 6th November 2026 | TEVA | 09-Oct-26 | 27-Oct-26 | Manufacturing delay | PERINDOPRIL TOSILATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL TOSILATE TEVA 5MG FC TABS | 30TABS | 39109 | Dec-26 | TEVA | 01-Oct-26 | 02-Oct-26 | Manufacturing delay | PERINDOPRIL TOSILATE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PINACORT 3MG MOD REL HARD CAPS | 100CAPS | 67118 | Unable to provide date | PINEWOOD | 03-Nov-25 | 24-Jul-26 | No reason provided | BUDESONIDE | As per Pinewood | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PIRFENIDONE CLONMEL 267MG FC TABS | 252TABS | 89259 | 11th November 2026 | CLONMEL | 27-Oct-26 | Manufacturing delay | PIRFENIDONE | As per HPRA | |||
| PIRFENIDONE TEVA 801MG FC TABS | 84TABS | 89242 | Nov-26 | TEVA | 04-Aug-26 | 27-Aug-26 | Manufacturing delay | PIRFENIDONE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PLERIXAFOR ACCORD 20MG/ML SOLN/INJ 1.2ML | 1VIAL | TBC | ACCORD HC | 23-Feb-26 | 27-Mar-26 | No reason provided | As per Accord | ||||
| POMALIDOMIDE TEVA 1MG HARD CAPS | 21CAPS | 89385 | OOS expected 1st November. Return date 6th November 2026 | TEVA | 23-Oct-26 | Manufacturing delay | POMALIDOMIDE | As per HPRA | |||
| POMALIDOMIDE TEVA 2MG HARD CAPS | 21CAPS | 89386 | Mar-27 | TEVA | 09-Oct-26 | 27-Oct-26 | Manufacturing delay | POMALIDOMIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| POMALIDOMIDE TEVA 3MG HARD CAPS | 21CAPS | 89387 | 6th November 2026 | TEVA | 09-Oct-26 | 27-Oct-26 | Manufacturing delay | POMALIDOMIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| POMALIDOMIDE TEVA 4MG HARD CAPS | 21CAPS | 89388 | OOS expected 1st November. Return date 6th November 2026 | TEVA | 23-Oct-26 | Manufacturing delay | POMALIDOMIDE | As per HPRA | |||
| PRASUGREL VIATRIS 10MG FC TABS | 28PACK | 37407 | TBC | VIATRIS | 15-Sep-25 | 24-Jun-26 | Manufacturing delay | PRASUGREL | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREDNISOLONE 1MG TABS | 250TABS | 78304 | TBC | CLONMEL | 17-Jul-25 | 19-Oct-26 | Manufacturing delay | PREDNISOLONE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| PREGABALIN SANDOZ 150MG HARD CAPS | 56CAPS | 36951 | 2nd October 2026 (ETA) | ROWA | 10-Jul-26 | 21-Sep-26 | Manufacturing delay | PREGABALIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ 200MG HARD CAPS | 84CAPS | 36952 | Discontinued | ROWA | 20-Mar-25 | 05-Oct-26 | 05-Oct-26 | Delay due to packing line adjustments | Licence withdrawn. Disc 06.08.26 FH | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ 75MG HARD CAPS | 56CAPS | 36948 | TBC | ROWA | 08-Apr-26 | 05-Oct-26 | Increase in sales | PREGABALIN | As per Rowa. License withdrawn on EMA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN TEVA 75MG HARD CAPS | 56CAPS | 37002 | Nov-26 | TEVA | 18-Sep-26 | 29-Oct-26 | Manufacturing delay | PREGABALIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREMARIN 0.625MG PRO REL TABS | 28TABS | 62063 | OOS expected 2nd November. Return date 20th November 2026 | PFIZER | 21-Oct-26 | Unexpected increased demand | CONJUGATED ESTROGENS | As per HPRA | |||
| PREMARIN 1.25MG PRO REL TABS | 28TABS | 62071 | 9th November 2026 | PFIZER | 19-Oct-26 | 28-Oct-26 | Unexpected increased demand | CONJUGATED ESTROGENS | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| PRO-EPANUTIN 75MG/ML CONSOL/INJ/INF 10ML | 10VIAL | 30th October 2026 | PFIZER | 24-Aug-26 | 09-Oct-26 | Manufacturing delay | FOSPHENYTOIN | As per HPRA | |||
| PROPESS 10MG VAGINAL DELIVERY SYSTEM | 5DEVICE | Back In Stock | FERRING | 08-Sep-26 | 08-Oct-26 | 08-Oct-26 | Manufacturing delay | DINOPROSTONE | No longer on HPRA list | ||
| QUESTRAN 4G/SACHET PDR FOR ORAL SUSP | 50SACH | 44329 | 30th March 2027 | ATHENA | 15-Jul-26 | 30-Oct-26 | Delivery delay | COLESTYRAMINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX XR 200MG PRO REL TABS | 60TABS | 45168 | Oct-26 | ROWA | 03-Feb-25 | 19-Oct-26 | Pharmathen supply issues | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX XR 300MG PRO REL TABS | 60TABS | 45169 | TBC | ROWA | 14-Jun-24 | 05-Oct-26 | Pharmathen supply issues | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX XR 50MG PRO REL TABS | 60TABS | 46021 | TBC | ROWA | 26-Mar-25 | 05-Oct-26 | Pharmathen supply issues | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETIAPINE KRKA 300MG FC TABS | 60TABS | 46023 | Back In Stock | KRKA PHARM | 18-Feb-26 | 27-Oct-26 | 27-Oct-26 | No reason provided | QUETIAPINE | As per KRKA | EMP reimbursed for duration of HPRA registered shortage |
| RAMIPRIL TEVA PHARMA 1.25MG TABS | 28TABS | 50034 | OOS expected 12th November. Return date 20th November 2026 | TEVA | 28-Oct-26 | Manufacturing delay | RAMIPRIL | As per HPRA | |||
| RAMIPRIL TEVA PHARMA 10MG TABS | 28TABS | 50037 | OOS expected 29th October. Return date 11th December 2026 | TEVA | 15-Oct-26 | 19-Oct-26 | Manufacturing delay | RAMIPRIL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RAMITACE 2.5MG TABS RAMIPRIL | 28TABS | 43065 | End October 2026 | CLONMEL | 13-Aug-26 | 28-Sep-26 | Manufacturing delay | RAMIPRIL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RHINOLAST 140MCG/SPRAY NASAL SPRAY | 20ML | 44204 | 2nd October 2026 | COOPER CH | 22-Sep-26 | 29-Sep-26 | Manufacturing delay | AZELASTINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RIDATE 35MG ONCE WEEK FC TABS RISEDRONAT | 4TABS | 44290 | 24th November 2026 | ROWA | 02-Oct-26 | 15-Oct-26 | Manufacturing delay | RISEDRONATE SODIUM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RIFADIN 100MG/5ML ORAL SUSPENSION | 120ML | 84077 | Back In Stock | SANOFI AVE | 23-Sep-26 | 27-Oct-26 | 27-Oct-26 | Supply constraints. Managing stock until next supply | RIFAMPICIN | As per Sanofi | Considered on a patient specific basis |
| RIFADIN 600MG PDR+SOLV CONC FOR SOLN/INF | 1VIAL | TBC | SANOFI AVE | 23-Sep-26 | 06-Oct-26 | Supply constraints. Managing stock until next supply | RIFAMPICIN | As per Sanofi | |||
| RISONTEL 35MG ONCE A WEEK TABS RISEDRONA | 4TABS | 50703 | End October 2026 | CLONMEL | 12-Jun-26 | 24-Jul-26 | Manufacturing delay | RISEDRONATE SODIUM | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RISPEVA 1MG FC TABS RISPERIDONE | 20TABS | 45309 | Back In Stock | TEVA | 11-Feb-26 | 02-Oct-26 | 01-Oct-26 | Awaiting release | RISPERIDONE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| RISPEVA 4MG FC TABS RISPERIDONE | 60TABS | 45390 | 29th January 2027 | TEVA | 13-Oct-26 | 27-Oct-26 | Manufacturing delay | RISPERIDONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RISPONE 1MG FC TABS RISPERIDONE | 60TABS | 44080 | 1st January 2027 | ROWA | 18-Sep-26 | 05-Oct-26 | Increase in sales | RISPERIDONE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RIVAROXABAN ACCORD 15MG FC TABS | 28TABS | 67369 | 16th December 2026 | ACCORD HC | 19-Oct-26 | 28-Oct-26 | Manufacturing delay | RIVAROXABAN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RIVAROXABAN ACCORD 2.5MG FC TABS | 56TABS | 67233 | Pending | ACCORD HC | 01-Oct-26 | 15-Oct-26 | Manufacturing delay | RIVAROXABAN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROLYPREXA 5MG FC TABS OLANZAPINE | 28TABS | 32971 | 1st December 2026 | ROWA | 07-Aug-26 | 05-Oct-26 | Delayed delivery | OLANZAPINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 10MG FC TABS | 28TABS | 62866 | 2nd November 2026 | VIATRIS | 01-Apr-26 | 04-Sep-26 | Manufacturing delay | ROSUVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 20MG FC TABS | 28TABS | 62867 | 2nd November 2026 | VIATRIS | 01-Apr-26 | 04-Sep-26 | Manufacturing delay | ROSUVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 40MG FC TABS | 28TABS | 62868 | 2nd November 2026 | VIATRIS | 06-Jul-26 | 17-Aug-26 | Manufacturing delay | ROSUVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 5MG FC TABS | 28TABS | 62865 | 2nd November 2026 | VIATRIS | 06-Jul-26 | 20-Jul-26 | Manufacturing delay | ROSUVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SAMETEC AIRMASTER 50MCG/100MCG 60 DOSE | 1DISK | 34457 | TBC | CLONMEL | 12-Oct-26 | 19-Oct-26 | No reason provided | SALMETEROL/FLUTICASO PROP | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SAMETEC AIRMASTER 50MCG/250MCG 60 DOSE | 1DISK | 34458 | TBC | CLONMEL | 04-Jun-26 | 16-Jun-26 | Manufacturing delay | SALMETEROL/FLUTICASO PROP | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SAMETEC AIRMASTER 50MCG/500MCG 60 DOSE | 1DISK | 34459 | OOS expected 30th October. Return date pending | CLONMEL | 16-Oct-26 | 28-Oct-26 | Shipping delay / distribution issue | SALMETEROL/FLUTICASO PROP | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SAVLON ANTISEPTIC CREAM | 30G | TBC | CLONMEL | 10-Jun-26 | 07-Jul-26 | No reason provided | CETRIMIDE/CHLORHEXIDINE | As per HPRA | |||
| SAVLON ANTISEPTIC CREAM | 60G | TBC | CLONMEL | 14-Nov-25 | 10-Jun-26 | Manufacturing delay | CETRIMIDE/CHLORHEXIDINE | As per Clonmel. | |||
| SENOKOT 7.5MG TABS | 20TABS | In Stock | RECKITTS | 28-Aug-26 | 15-Oct-26 | 15-Oct-26 | Manufacturing delay | SENNOSIDE B | No longer on HPRA list. 500 pack now listed as short | ||
| SENOKOT 7.5MG TABS | 500TABS | 7th December 20026 | RECKITTS | 13-Oct-26 | Manufacturing delay | SENNOSIDE B | As per HPRA | ||||
| SERLAN TABS 50MG SERTRALINE | 28TABS | 78435 | 20th November 2026 | ROWA | 16-Oct-26 | 28-Oct-26 | Manufacturing delay | SERTRALINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SEROPIA XR 50MG PRO REL TABS QUETIAPINE | 60TABS | 46095 | 1st January 2027 | CLONMEL | 12-Oct-25 | 13-Oct-26 | Manufacturing delay | QUETIAPINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 150MG PRO REL TABS | 60TABS | 45872 | TBC | ATHENA | 26-Aug-26 | 31-Aug-26 | Unexpected increased demand | QUETIAPINE | As per Athena | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 150MG PRO REL TABS ORIGINAL | 60TABS | No resupply date | ORIGINALIS | 18-Nov-25 | Low sales price in Ireland and demand | QUETIAPINE | As per Originals | ||||
| SEROQUEL XR 200MG PRO REL TABS PCO | 60TABS | 66923 | Intermittent supply - Limited supply | PCO | 12-Nov-25 | 22-May-26 | No reason provided | QUETIAPINE | As per PCO | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 300MG PRO REL TABS | 60TABS | 45848 | 30th January 2027 | ATHENA | 26-Aug-26 | 07-Sep-26 | Unexpected increased demand | QUETIAPINE | As per Athena / HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 400MG PRO REL TABS | 60TABS | 45863 | TBC | ATHENA | 26-Aug-26 | 31-Aug-26 | Unexpected increased demand | QUETIAPINE | As per Athena | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 400MG PRO REL TABS ORIGINAL | 60TABS | 31142 | No resupply date | ORIGINALIS | 18-Nov-25 | 20-May-26 | Low sales price in Ireland and demand | QUETIAPINE | As per Originalis | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 50MG PRO REL TABS | 60TABS | 45812 | Pending | ATHENA | 12-Oct-26 | 19-Oct-26 | Unexpected increase in demand | QUETIAPINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 50MG PRO REL TABS PCO | 60TABS | 29216 | No return to stock date | PCO | 12-Nov-25 | 15-Jul-26 | No reason provided | QUETIAPINE | As per PCO | EMP reimbursed for duration of HPRA registered shortage | |
| SERTRALINE KRKA 100MG FC TABS | 28TABS | 50561 | 31st October 2026 | KRKA PHARM | 19-Nov-25 | 27-Oct-26 | No reason provided | SERTRALINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SERTRALINE KRKA 50MG FC TABS | 28TABS | 50560 | 31st October 2026 | KRKA PHARM | 19-Nov-25 | 27-Oct-26 | No reason provided | SERTRALINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SEVELAMER CARBONATE 800MG FC TABS | 180TABS | 43916 | 30th November 2026 | VIATRIS | 09-Sep-26 | 15-Sep-26 | Manufacturing delay | SEVELAMER CARBONATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SILDENAFIL CLONMEL 25MG FC TABS | 4TABS | 33534 | Back In Stock | CLONMEL | 28-Aug-26 | 12-Oct-26 | 12-Oct-26 | Unexpected increased demand | SILDENAFIL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| SIMVASTATIN TEVA 10MG FC TABS | 28TABS | 38230 | 20th November 2026 | TEVA | 23-Oct-26 | Manufacturing delay | SIMVASTATIN | As per HPRA | |||
| SIMVASTATIN TEVA 20MG FC TABS | 28TABS | 38247 | Dec-26 | TEVA | 08-Apr-26 | 03-Sep-26 | Manufacturing delay | SIMVASTATIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SIMVASTATIN TEVA 40MG FC TABS | 28TABS | 38256 | 15th January 2027 | TEVA | 09-Oct-26 | 27-Oct-26 | Manufacturing delay | SIMVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SINEMET 12.5MG/50MG TABS | 100TABS | 66912 | 2nd November 2026 | ORGANON | 08-Oct-26 | 27-Oct-26 | Manufacturing delay | CARBIDOPA/LEVODOPA | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SINGULAIR 10MG FC TABS | 28TABS | 46334 | 16th November 2026 | ORGANON | 25-Sep-26 | 12-Oct-26 | Unexpected increased demand | MONTELUKAST | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SITAGLIPTIN ACCORD 25MG FC TABS | 28TABS | 66882 | 1st December 2026 | ACCORD HC | 28-Oct-26 | Unexpected increased demand | SITAGLIPTIN | As per HPRA | |||
| SITAGLIPTIN ACCORD 50MG FC TABS | 28TABS | 66883 | 5th December 2026 | ACCORD HC | 29-Oct-26 | Unexpected increased demand | SITAGLIPTIN | As per HPRA | |||
| SITAGLIPTIN KRKA 25MG FC TABS | 28TABS | 66816 | 15th January 2027 | KRKA PHARM | 29-Oct-26 | Unexpected increased demand | SITAGLIPTIN | As per HPRA | |||
| SKINOREN 15% GEL | 30G | 46830 | 14th November 2026 | LEO PHARMA | 14-Oct-26 | 19-Oct-26 | API shortage / unavailability | AZELAIC ACID | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SOLPADOL CAPLETS 500MG/30MG TABS | 100TABS | 47082 | 17th November 2026. BSR stock available. | PHOENIX | 24-Feb-26 | 27-Oct-26 | API shortage / unavailability | PARACETAMOL/CODEINE PHOS | As per HPRA. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPERIZAK 25MG PDR + SOLV PROREL SUSP/INJ | 1VIAL | Discontinued | ACCORD HC | 23-Jul-25 | 28-Oct-26 | 28-Oct-26 | Shipping delay / distribution issue | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | ||
| SPERIZAK 37.5MG PDR + SOLV PROREL INJ | 1VIAL | Discontinued | ACCORD HC | 23-Jul-25 | 28-Oct-26 | 28-Oct-26 | Shipping delay / distribution issue | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | ||
| SPERIZAK 50MG PDR + SOLV PROREL INJ | 1VIAL | Discontinued | ACCORD HC | 23-Jul-25 | 28-Oct-26 | 28-Oct-26 | Shipping delay / distribution issue | As per Accord. (HPRA shows Pendig return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | ||
| SPIRONOLACTONE 100MG FC TABS | 100TABS | 72816 | Nov-26 | ACCORD HC | 23-Feb-26 | 15-Sep-26 | Delayed | SPIRONOLACTONE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| STELAZINE 1MG TABS | 112TABS | No confirmed timeline. (HPRA shows 1 Jan 2027 return date) | ADVANZ | 05-Jun-26 | 20-Oct-26 | Manufacturing delay | TRIFLUOPERAZINE | As per Advanz / HPRA | |||
| SUGAMMADEX TEVA 100MG/ML SOLN/INJ 2ML | 10VIAL | TBC | TEVA | 17-Aug-26 | 05-Oct-26 | API Shortage / Unavailablity | SUGAMMADEX | As per Teva | |||
| SUGAMMADEX TEVA 100MG/ML SOLN/INJ 5ML | 10VIAL | TBC | TEVA | 17-Aug-26 | 18-Sep-26 | API shortage / unavailability | SUGAMMADEX | As per HPRA | |||
| SUMATRAN 100MG TABS SUMATRIPTAN | 6TABS | 68374 | 1st December 2026 | ROWA | 13-Aug-26 | 21-Sep-26 | Unprecedented demand | SUMATRIPTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRAN 50MG TABS SUMATRIPTAN | 6TABS | 68359 | 30th October 2026 | ROWA | 08-Apr-26 | 17-Jul-26 | Increased demand | SUMATRIPTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRAN RELIEF 50MG TABS SUMATRIPTAN | 2TABS | 4th December 2026 | ROWEX | 16-Oct-26 | Manufacturing delay | SUMATRIPTAN | As per Rowa | ||||
| SUMATRIPTAN 100MG FC TABS | 6TABS | 36909 | No return date | ACCORD HC | 05-Feb-26 | 20-May-26 | Manufacturing delay | SUMATRIPTAN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRIPTAN 50MG FC TABS | 6TABS | 36908 | No return date | ACCORD HC | 05-Feb-26 | 20-May-26 | Manufacturing delay | SUMATRIPTAN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUPRAX 200MG TABS | 7TABS | 47544 | End June 2027 | ADVANZ | 18-Aug-26 | 30-Oct-26 | Manufacturing issue | CEFIXIME | As per Advanz. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TAMNIC 400MCG MOD REL HARD CAPS | 30CAPS | 46849 | End October 2026 | CLONMEL | 12-Oct-26 | 13-Oct-26 | No reason provided | TAMSULOSIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TAMSULOSIN 400MCG MOD REL HARD CAPS | 30CAPS | 50348 | Back In Stock | VIATRIS | 20-Jul-26 | 27-Oct-26 | 27-Oct-26 | Unexpected increased demand | TAMSULOSIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| TELMISARTAN HCTZ ROWA 80MG/12.5MG TABS | 28TABS | 13164 | TBC | ROWA | 04-May-26 | 05-Oct-26 | Unexpected increased demand | TELMISARTAN/HCTZ | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TEMOZOLOMIDE CLONMEL 250MG HARD CAPS | 5CAPS | 88519 | End October 2026 | CLONMEL | 31-Aug-26 | 12-Oct-26 | No reason provided | TEMOZOLOMIDE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TENDROTIL SR 2MG PRO REL HARD CAPS | 28CAPS | 31598 | No return date | ACCORD HC | 04-Feb-25 | 20-May-26 | Quality issue | TOLTERODINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TENDROTIL SR 4MG PRO REL HARD CAPS | 28CAPS | 31643 | No return date | ACCORD HC | 17-Dec-24 | 20-May-26 | Quality issue | TOLTERODINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TEVAQUEL XL 200MG PRO REL TAB QUETIAPINE | 60TABS | 65997 | Nov-26 | TEVA | 15-Sep-26 | 02-Oct-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL XL 300MG PRO REL TAB QUETIAPINE | 60TABS | 67832 | Nov-26 | TEVA | 23-Jun-25 | 24-Sep-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL XL 400MG PRO REL TAB QUETIAPINE | 60TABS | 67965 | TBC | TEVA | 16-Sep-26 | 30-Sep-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL XL 50MG PRO REL TABS QUETIAPINE | 60TABS | 65982 | Nov-26 | TEVA | 24-Nov-25 | 24-Sep-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TIPURIC 100MG TABS ALLOPURINOL | 100TABS | 11363 | TBC | CLONMEL | 06-Jul-26 | 13-Oct-26 | API shortage / unavailability | ALLOPURINOL | As per Clonmel. HPRA shows 1 Jan 27 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TIPURIC 300MG TABS ALLOPURINOL | 100TABS | 11398 | TBC | CLONMEL | 13-Apr-26 | 28-Sep-26 | No reason provided | ALLOPURINOL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TOLTERODINE TARTRATE 2MG FC TABS | 56TABS | 36894 | Jan-27 | ACCORD HC | 20-Mar-25 | 15-Sep-26 | Manufacturing delay | TOLTERODINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TOVIAZ 4MG PRO REL TABS | 28TABS | 47553 | 4th December 2026 | PFIZER | 24-Sep-26 | 27-Oct-26 | Unexpected increased demand | FESOTERODINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TOVIAZ 8MG PRO REL TABS | 28TABS | 47575 | 16th December 2026 | PFIZER | 06-Aug-26 | 27-Oct-26 | Unexpected increased demand | FESOTERODINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRACRIUM 10MG/ML SOLN/INJ/INF 2.5ML AMPS | 5AMP | TBC | SANDOZ | 16-Jan-26 | 09-Sep-26 | Manufacturing delay | ATRACURIUM | As per Rowa | |||
| TRACTOCILE 6.75MG/0.9ML SOLN FOR INJ | 1VIAL | 31st October 2026 | FERRING | 11-Sep-26 | Unexpected increased demand | ATOSIBAN | As per HPRA | ||||
| TRAMADOL/PARACETAMOL ROWA 37.5/325MG TAB | 60TABS | 48595 | Mid October 2026 | ROWA | 17-Jul-26 | 05-Oct-26 | Increased demand | TRAMADOL/PARACETAMOL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRUSITEV SR 2MG PRO REL HARD CAPS | 28CAPS | 42046 | Jan-27 | TEVA | 09-Jan-25 | 15-Oct-26 | No reason provided | TOLTERODINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRUSITEV SR 4MG PRO REL HARD CAPS | 28CAPS | 42052 | Jan-27 | TEVA | 13-Feb-25 | 15-Oct-26 | No reason provided | TOLTERODINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TYVENSE 40MG HARD CAPS | 28TABS | 28755 | In Stock | TAKEDA IRL | 31-Aug-26 | 27-Oct-26 | 27-Oct-26 | Unexpected increased demand | LISDEXAMFETAMINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| UPTRAVI 200MCG FC TABS | 60TABS | 88975 | In Stock | JANSSEN | 16-Oct-26 | 27-Oct-26 | 27-Oct-26 | Shipping delay / distribution issue | SELEXIPAG | No longer on HPRA list | |
| UPTRAVI 400MCG FC TABS | 60TABS | 88977 | In Stock | JANSSEN | 16-Oct-26 | 27-Oct-26 | 27-Oct-26 | Shipping delay / distribution issue | SELEXIPAG | No longer on HPRA list | |
| UROGRAFIN 30% SOLN FOR INF | 250ML | 2027 | BAYER | 10-Mar-26 | 30-Sep-26 | Quality issue | SOD AMIDOTRI/MEGLUM AMIDO | As per Bayer | |||
| URSOFALK 250MG HARD CAPS | 100CAPS | 48569 | OOS expected 10th November. Return date 30th November 2026 | DR FALK | 16-Oct-26 | 28-Oct-26 | Manufacturing delay | URSODEOXYCHOLIC ACID | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VAGIFEM 10MCG VAGINAL TABS | 24vagtab | 51303 | Product on Allocation from the supplier. Stock resets and available again on the 1st | NOVO NRDSK | 29-Sep-26 | Stock magement | ESTRADIOL | As per Allphar / Novo Nordisk | |||
| VAGIRUX 10MCG VAGINAL TABS | 24vagtab | 34449 | 1st December 2026 | GEDEON RCH | 09-Oct-26 | 19-Oct-26 | Unexpected increased demand | ESTRADIOL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALACICLOVIR TEVA 500MG FC TABS | 30TABS | 60563 | Dec-26 | TEVA | 22-Sep-26 | 08-Oct-26 | Manufacturing delay | VALACICLOVIR | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALGANCICLOVIR ACCORD 450MG FC TABS | 60TABS | 88633 | In Stock | ACCORD HC | 11-Sep-26 | 14-Oct-26 | 14-Oct-26 | Manufacturing delay | VALGANCICLOVIR | No longer on HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VALOTIX 500MG FC TABS VALACICLOVIR | 10TABS | 51410 | November 2026 (ETA) | ROWEX | 16-Oct-26 | 28-Oct-26 | Manufacturing delay | VALACICLOVIR | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALSARTAN VIATRIS 40MG FC TABS | 28TABS | 73780 | 15th November 2026 | VIATRIS | 02-Sep-26 | 15-Sep-26 | Unexpected increased demand | VALSARTAN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALTAN 40MG FC TABS VALSARTAN | 28TABS | 73777 | End October 2026 | CLONMEL | 12-Oct-26 | 19-Oct-26 | No reason provided | VALSARTAN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALTREX 500MG FC TABS PCO | 30TABS | 66944 | No return to stock date | PCO | 17-Jun-26 | 08-Jul-26 | No reason provided | VALACICLOVIR | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VARENICLINE TEVA 0.5MG + 1MG FC TABS | 1PACK | 67441 | TBC | TEVA | 03-Sep-26 | 27-Oct-26 | Manufacturing delay | VARENICLINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VARENICLINE TEVA 1MG FC TABS | 56TABS | 67442 | TBC | TEVA | 03-Sep-26 | 17-Sep-26 | Manufacturing delay | VARENICLINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VATAN 40MG FC TABS | 28TABS | 73794 | Back In Stock | ROWA | 18-Sep-26 | 19-Oct-26 | 16-Oct-26 | Production delays | VALSARTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VAXIGRIP FLU VACCINE PFS 2026-2027 | 1SYR | Limited stocks available | SANOFI WIN | 10-Sep-26 | 27-Oct-26 | Manufacturing delay | TRIVALENT FLU VACCINE | As per Sanofi / Uniphar | |||
| VENLATEV 150MG PRO REL HARD CAPS | 28CAPS | 67246 | 13th November 2026 | TEVA | 25-Sep-26 | 12-Oct-26 | Manufacturing delay | VENLAFAXINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VENLOFEX 150MG PRO REL CAPS VENLAFAXINE | 28CAPS | 79172 | 30th November 2026 | VIATRIS | 04-Apr-25 | 15-Jun-26 | Manufacturing delay | VENLAFAXINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VERORAB PDR & SOLV FOR SUSP/INJ POA | 1VIAL | 1st January 2027 | SANOFI WIN | 04-Sep-26 | Manufacturing delay | RABIES VIRUS | As per HPRA | ||||
| VIDENE 10% ALCOHOLIC TINCTURE | 500ML | Pending | ECOLAB | 19-Nov-25 | 05-Jan-26 | Manufacturing delay | POVIDONE-IODINE | As per HPRA | |||
| VIDISIC 0.2% EYE GEL CARBOMER | 10G | 52175 | Pending | BAUSCH&L | 19-Oct-26 | 28-Oct-26 | Manufacturing delay | CARBOMER | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VIDISIC 0.2% PRESERVATIVE FREE SDU | 30UDV | 33451 | Pending | BAUSCH&L | 19-Oct-26 | 28-Oct-26 | Manufacturing delay | CARBOMER | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VIRALIEF 50MG/G CREAM ACICLOVIR | 2G | Apr-27 | CLONMEL | 21-May-26 | 13-Oct-26 | Quality issue | ACICLOVIR | As per HPRA | |||
| VITAFEN 100MG FC TABS | 60TABS | 35974 | Q3 2026 | PHOENIX | 15-Apr-25 | 24-Aug-26 | Awaiting approval on submission to the HPRA | ACECLOFENAC | As per Phoenix Labs. Exempt Medicinal Product avail. Temp code 55557 applies | Temporary code of 55557 | |
| VIZIMPRO 30MG FC TABS | 30TABS | 88828 | In Stock | PFIZER | 14-Sep-26 | 16-Oct-26 | 16-Oct-26 | Manufacturing delay | DACOMITINIB | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VIZIMPRO 45MG FC TABS | 30TABS | 88829 | In Stock | PFIZER | 16-Sep-26 | 16-Oct-26 | 16-Oct-26 | Manufacturing delay | DACOMITINIB | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VOLTAROL 50MG GAST RES TABS | 50TABS | 55279 | Back In Stock | NOVARTIS | 30-Sep-26 | 16-Oct-26 | 16-Oct-26 | Increased sales | DICLOFENAC SODIUM | As per Novartis | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VYDURA 75MG ORAL LYOPHILISATE | 2TABS | 89391 | 19th October 2026 | PFIZER | 09-Oct-26 | 19-Oct-26 | Unexpected increased demand | RIMEGEPANT | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| XARELTO 1MG/ML GRANULES FOR ORAL SUSP | 51.7ML | 19th December 2026 | BAYER | 15-Jun-26 | 20-Oct-26 | Unexpected increased demand | RIVAROXABAN | As per HPRA | |||
| XYMEL COMP 37.5MG/325MG FC TABS | 60TABS | 52750 | TBC | CLONMEL | 07-Jul-26 | 28-Sep-26 | No reason provided | TRAMADOL/PARACETAMOL | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZADITEN 0.25MG/ML EYE DROPS SOLN | 5ML | 63281 | End May / June 2027 | LAB THEA | 11-Jul-25 | 06-Oct-26 | Quality issue | KETOTIFEN | As per Lab Thea | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZANIDIP 10MG FC TABS IMED | 28TABS | 67385 | In Stock | IMED | 25-Sep-26 | 27-Oct-26 | 27-Oct-26 | Unexpected increased demand | LERCANIDIPINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ZANIDIP 20MG FC TABS | 28TABS | 63804 | In Stock | RECORDATI | 13-Aug-26 | 27-Oct-26 | 27-Oct-26 | Unexpected increased demand | LERCANIDIPINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ZESTAN 20MG TABS LISINOPRIL | 28TABS | 53814 | Back In Stock | CLONMEL | 06-Jul-26 | 12-Oct-26 | 12-Oct-26 | Manufacturing delay | LISINOPRIL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ZINDACLIN 1% GEL | 30G | 59816 | 31st October 2026 | ASPIRE PH | 06-Mar-23 | 27-Oct-26 | Distribution issue | CLINDAMYCIN | As per HPRA. EMP avail. HPRA shows PA23142/016/001 as Not Marketed Oct 2026 | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZINNAT 500MG FC TABS | 14TABS | 59896 | End November 2026 | SANDOZ | 18-Sep-26 | 19-Oct-26 | Manufacturing delay | CEFUROXIME | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZITHROMAX 250MG CAPS | 6CAPS | 59919 | 22nd October 2026 | PFIZER | 24-Aug-26 | 19-Oct-26 | Unexpected increased demand | AZITHROMYCIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOFRAN 4MG FC TABS | 30TABS | 53163 | 16th November 2026 | ROWEX | 08-May-26 | 29-Oct-26 | Increase in sales | ONDANSETRON | As per HPRA. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOFRAN 4MG/2ML SOLN/INJ/INF | 10AMP | End November 2026 | ROWEX | 01-Oct-25 | 19-Oct-26 | Delay receiving stock | ONDANSETRON | As per Rowa | |||
| ZOFRAN 8MG FC TABS | 30TABS | 53155 | Early November 2026 (ETA) | ROWEX | 05-Jun-26 | 19-Oct-26 | Manufacturing delay | ONDANSETRON | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOLSKETIL PEGYLATED LIPOSOMO 2MG/ML 25ML | 1VIAL | TBC | ACCORD HC | 15-Jul-26 | 15-Sep-26 | Need to discuss with Manufacturer. | DOXORUBICIN LIPOSOMAL | As per Accord | |||
| ZONISAMIDE ROWEX 100MG HARD CAPS | 56CAPS | 67338 | Back In Stock | ROWA | 18-Sep-26 | 19-Oct-26 | 16-Oct-26 | Manufacturing delay | ZONISAMIDE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ZOVIRAX 200MG/5ML ORAL SUSPENSION | 125ML | 54798 | 16th November 2026 | GSK MED | 18-Aug-26 | 17-Sep-26 | Unexpected increased demand | ACICLOVIR | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOVIRAX DOUBLE STRENGTH 400MG/5ML SUSP | 100ML | 55850 | 30th November 2026 | GSK MED | 28-Sep-26 | 19-Oct-26 | Unexpected increased demand | ACICLOVIR | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list |
💊
Ask a question
about medicine shortages
about medicine shortages
By chatting, you agree to this
.
/* Mobile only */
@media (min-width: 769px) {
#medicineBubble,
#medicineChatWrapper {
display: none !important;
}
}
/* Centered bubble */
#medicineBubble {
position: fixed;
inset: 0;
margin: auto;
width: 100px;
height: 100px;
background: #8CC63F;
border-radius: 50%;
box-shadow: 0 10px 25px rgba(0,0,0,.3);
z-index: 999999;
display: flex;
align-items: center;
justify-content: center;
text-align: center;
color: #fff;
font-size: 11px;
font-weight: 600;
cursor: pointer;
}
#medicineBubble .icon {
font-size: 24px;
display: block;
margin-bottom: 4px;
}
/* Chat wrapper (hidden initially) */
#medicineChatWrapper {
display: none; /* MUST be hidden initially */
position: fixed;
inset: 0;
width: 100vw;
height: 100dvh;
flex-direction: column;
z-index: 1000000;
background: #fff;
overflow: hidden;
display: none;
}
#medicineChatHeader {
padding: calc(8px + env(safe-area-inset-top, 0px)) 12px 8px 12px;
display: flex;
justify-content: flex-end;
background: rgba(0,0,0,.05);
flex-shrink: 0;
}
#closeMedicineChat {
background: rgba(0,0,0,.85);
color: #fff;
border: none;
padding: 8px 12px;
border-radius: 999px;
font-size: 14px;
}
#medicineChatIframe {
flex: 1;
width: 100%;
border: none;
}
// Force chat hidden on page load
document.getElementById('medicineChatWrapper').style.display = 'none';
function openMedicineChat() {
document.getElementById('medicineChatWrapper').style.display = 'flex';
document.getElementById('medicineBubble').style.display = 'none';
document.body.style.overflow = 'hidden';
}
function closeMedicineChat() {
document.getElementById('medicineChatWrapper').style.display = 'none';
document.getElementById('medicineBubble').style.display = 'flex';
document.body.style.overflow = '';
}
💊
Ask a question
about medicine shortages
about medicine shortages
By chatting, you agree to this .
